hg_97578.1

Basic information about the TSS

---

TSS ID: hg_97578.1 Species: human Chr: chr9		Start: 97633845 End: 97633856 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: X80030 Distance: 0 GeneID: 4686 HGNC/MGI_ID: HGNC:7658 UniProt_ID:

Gene_name: nuclear cap binding protein subunit 1 Gene_symbol: NCBP1 Gene_synonyms: CBP80 Sto1 Gene_source: HGNC:7658

TATA-Box annotation

---

Distance to TSS:	30
Nearest PromoterID:	NM_002486
Entrez ID:	4686
Nearest Unigene:	Hs.595669
Nearest Refseq:	NM_002486
Nearest Ensembl:	ENSG00000136937
Gene Name:	nuclear cap binding protein subunit 1
Gene Alias:	CBP80|NCBP|Sto1
Gene Description:	nuclear cap binding protein subunit 1
Gene Type:	protein-coding
CpG%:	0.145
GC%:	0.741294
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@NCBP1 p2@NCBP1 p3@NCBP1 p4@NCBP1 p5@NCBP1 p6@NCBP1 p8@NCBP1
Sample		p1@NCBP1	p2@NCBP1	p3@NCBP1	p4@NCBP1	p5@NCBP1	p6@NCBP1	p8@NCBP1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	41.88	12.47	3.90	2.53	0.78	0.78	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	33.18	13.56	3.64	1.42	0.81	1.42	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	33.37	14.27	2.12	3.09	0.58	0.58	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	29.32	10.60	3.74	2.08	0.83	0.83	0.21
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	33.29	12.82	3.15	1.12	0.22	1.12	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	33.92	11.24	2.13	0.58	0.97	0.58	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	43.58	15.47	4.36	1.53	1.31	2.40	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	51.35	11.63	4.84	1.70	1.45	0.97	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	32.70	11.33	3.42	2.99	0.64	1.28	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	63.76	15.07	3.48	2.32	2.32	1.74	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	63.46	10.11	2.43	2.02	1.21	1.21	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	74.40	14.23	2.85	1.22	1.22	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	7.25	5.96	3.22	2.26	0.64	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	8.42	6.77	2.26	1.50	0.60	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	9.44	5.27	1.98	1.54	0.66	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	6.79	8.80	3.02	0.50	0.50	0.00	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	6.12	6.99	3.28	1.31	0.44	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	8.44	4.64	2.53	1.27	1.69	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	12.26	6.40	2.13	0.53	1.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	6.77	6.32	2.86	1.20	0.30	0.30	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	8.82	7.22	2.81	1.20	0.94	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	8.98	6.39	2.42	0.86	1.21	0.00	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	8.53	4.65	2.59	1.29	0.90	0.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	7.04	7.04	1.46	1.21	0.97	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	8.51	5.93	2.84	1.03	0.26	0.00	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	6.96	5.38	2.85	0.95	0.95	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	10.99	7.14	3.30	0.55	0.55	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	9.67	6.13	4.01	2.12	0.71	0.00	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	6.14	4.68	3.07	0.81	0.65	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	7.78	5.25	3.26	1.45	0.72	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	8.16	4.19	0.84	1.05	1.05	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	4.30	3.91	1.56	1.76	0.39	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	7.81	5.70	4.22	1.90	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	8.74	7.75	4.45	0.16	0.82	0.00	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	7.48	5.98	1.87	1.50	0.75	0.19	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	5.37	5.37	3.26	1.53	0.77	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	7.36	4.29	1.84	0.82	1.64	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	6.25	5.44	4.43	1.61	0.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	5.13	7.29	3.24	2.16	0.54	0.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	4.32	6.00	4.56	1.68	0.48	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	9.88	5.18	2.82	1.18	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	8.64	4.98	2.93	1.02	1.17	0.59	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	6.12	5.48	4.64	1.69	0.21	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	7.17	5.24	2.80	1.75	0.52	0.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	8.03	8.43	3.61	1.00	0.80	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	7.68	5.82	4.19	1.16	1.40	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	6.72	5.28	3.84	1.68	0.24	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	9.24	8.35	3.87	1.49	0.60	0.60	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	6.46	5.74	4.79	1.20	1.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	8.90	8.29	3.24	1.01	0.40	0.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	10.25	8.40	4.30	1.43	0.20	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	9.12	6.23	4.23	0.89	0.67	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	41.98	55.97	0.00	13.99	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	7.10	9.58	4.26	1.42	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	9.28	6.96	5.63	2.65	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	37.75	13.42	5.03	5.03	1.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	16.07	10.10	6.43	0.92	0.92	0.46	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	10.05	7.78	7.13	1.62	0.00	0.32	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	5.78	5.46	4.82	2.89	0.32	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	13.52	9.74	3.46	1.57	2.20	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	7.05	4.94	2.12	0.00	0.71	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	7.29	8.41	6.17	2.80	0.00	0.56	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	19.11	7.17	4.78	1.59	2.39	0.00	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	13.93	7.14	3.74	0.68	0.00	0.68	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	8.45	5.52	3.25	2.92	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	7.81	5.68	5.68	2.48	0.00	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	48.49	16.16	16.16	16.16	16.16	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	63.18	15.79	15.79	23.69	0.00	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	5.36	5.36	2.44	2.44	0.49	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	5.95	5.45	5.45	3.97	0.50	0.50	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	6.10	6.57	7.04	2.81	0.94	0.00	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	4.97	6.62	2.98	0.99	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	5.88	5.26	4.02	1.55	0.00	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	3.67	6.73	2.14	2.45	0.00	0.31	0.00
Adipocyte - breast, donor1	11376-118A8	9.98	7.60	4.28	0.79	0.00	0.48	0.00
Adipocyte - breast, donor2	11327-117E4	9.63	5.13	3.53	1.76	0.64	0.16	0.00
Adipocyte - omental, donor1	11473-119C6	11.32	9.67	6.62	1.40	0.25	0.25	0.13
Adipocyte - omental, donor2	11474-119C7	3.74	2.99	1.49	1.49	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	8.37	5.36	6.70	1.34	0.33	0.33	0.00
Adipocyte - perirenal, donor1	11476-119C9	5.74	5.74	3.19	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	9.90	1.10	1.10	2.20	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	11.29	9.94	5.87	1.35	0.45	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	7.99	5.73	3.13	0.87	0.35	0.17	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	11.73	10.56	6.65	4.69	0.98	0.00	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	12.87	11.07	6.69	3.35	0.77	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	10.31	11.99	3.62	2.23	0.28	0.00	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	12.93	9.99	8.23	2.35	1.76	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	17.78	11.50	6.43	3.30	0.88	0.48	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	13.23	7.42	4.84	1.94	0.32	0.00	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	9.06	9.60	2.13	1.07	1.60	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	11.13	5.56	3.34	2.78	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	9.57	6.24	7.49	2.08	0.83	0.00	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	9.29	6.28	2.76	1.76	0.00	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	8.18	7.53	3.27	2.29	0.65	0.00	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	5.18	6.39	3.65	1.83	0.61	0.91	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	7.51	6.41	1.10	3.54	0.44	0.66	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	4.30	4.30	2.15	1.43	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	0.00	0.00	0.00	0.00	1.20	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	9.71	6.30	2.70	2.16	1.08	0.72	0.54
Amniotic Epithelial Cells, donor2	11613-122A2	10.04	1.67	5.02	1.67	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	2.47	3.29	2.05	1.85	0.00	0.41	0.00
Anulus Pulposus Cell, donor1	11248-116E6	8.01	8.81	5.84	1.83	0.46	0.00	0.11
Anulus Pulposus Cell, donor2	11463-119B5	6.61	6.61	3.67	0.73	0.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	8.09	5.84	4.94	1.80	0.00	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	9.55	4.34	3.47	0.87	0.87	0.00	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	14.98	6.42	2.14	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	7.47	5.38	3.59	1.49	0.30	0.30	0.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	8.85	7.59	2.53	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	5.94	9.90	0.00	0.00	0.66	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	8.12	4.55	3.25	0.65	0.32	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	6.80	5.83	6.80	0.00	0.49	0.00	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	4.16	7.72	2.97	1.19	0.00	0.59	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	9.42	6.78	3.01	0.00	0.38	0.00	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	6.53	7.26	1.45	0.73	0.00	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	3.76	7.52	1.25	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	9.55	9.55	2.47	0.33	0.66	0.66	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	8.19	6.82	1.36	0.00	0.00	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	5.73	7.24	3.77	1.21	0.90	0.00	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	8.04	6.97	2.68	0.54	0.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	9.26	6.42	3.97	0.94	0.38	0.76	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	7.48	8.02	5.08	0.80	0.80	0.00	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	5.85	5.85	0.00	0.00	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	7.63	4.48	1.82	0.83	0.33	0.66	0.17
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	10.81	6.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	0.00	3.54	3.54	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	6.35	5.83	2.06	1.03	0.69	0.17	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	0.00	4.19	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	7.77	3.40	1.94	0.97	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	11.76	9.11	1.52	0.38	0.00	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	6.06	12.11	4.85	0.00	2.42	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	7.98	7.41	3.99	0.00	0.00	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	7.91	5.56	4.49	0.43	0.43	0.86	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	6.71	5.42	2.84	1.29	0.00	0.52	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	6.57	5.63	4.22	1.88	0.00	0.47	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	9.97	5.79	2.25	1.93	0.96	0.64	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	8.56	9.27	3.57	0.71	0.71	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	5.26	5.26	2.34	0.58	1.17	0.58	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	8.73	5.12	3.01	0.90	0.30	0.60	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	5.94	9.50	1.19	0.00	0.00	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	7.12	7.63	2.54	1.53	1.02	1.53	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	11.21	6.62	3.57	1.27	1.02	0.00	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	5.72	3.81	2.54	0.64	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	3.88	7.34	3.88	0.86	0.43	0.00	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	9.31	5.08	2.12	1.06	0.64	0.00	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	3.19	6.38	4.06	0.58	0.00	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	7.56	9.45	0.00	1.89	0.94	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	7.12	4.07	2.71	1.02	0.34	0.34	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	4.63	4.63	4.63	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	10.56	10.56	0.00	2.11	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	4.93	6.86	2.14	1.29	0.64	0.00	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	6.02	6.02	1.80	0.00	0.00	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	5.83	2.92	0.73	2.19	1.46	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	6.90	4.60	2.30	0.92	0.69	0.46	0.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	15.30	2.55	5.10	2.55	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	8.90	5.08	2.03	0.00	0.00	0.25	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	6.19	7.23	3.10	0.21	0.62	0.21	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	5.81	4.59	1.53	0.00	0.92	0.31	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	9.08	5.26	2.39	0.96	0.00	0.48	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	7.54	5.54	4.66	1.55	0.44	0.89	0.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	6.10	3.05	3.05	0.00	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	5.54	2.77	2.22	1.66	1.66	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	8.47	8.21	3.44	1.06	0.53	0.26	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	4.36	5.45	3.63	0.36	0.00	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	6.39	8.11	4.54	4.05	0.37	0.61	0.12
Astrocyte - cerebellum, donor2	11580-120F5	3.77	6.68	3.25	2.91	0.34	0.34	0.00
Astrocyte - cerebellum, donor3	11661-122F5	1.68	2.10	1.89	1.47	0.21	0.63	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	18.82	13.59	7.67	6.27	0.70	1.05	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	16.50	20.38	6.96	5.50	0.81	1.46	0.97
Astrocyte - cerebral cortex, donor3	11392-118C6	17.45	15.36	9.99	9.99	0.75	0.75	0.60
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	25.46	37.27	12.16	4.36	2.52	1.03	0.34
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	27.31	35.08	10.52	4.64	2.76	0.50	0.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	31.64	40.97	11.61	5.92	2.05	1.14	0.57
Basophils, donor1	12241-129G9	12.29	7.58	6.80	1.05	0.00	2.09	0.26
Basophils, donor2	12242-129H1	18.40	34.64	29.59	0.36	1.44	5.05	0.72
Basophils, donor3	12243-129H2	9.85	6.76	5.29	0.88	1.18	1.62	0.73
Bronchial Epithelial Cell, donor1	11511-119G8	3.88	2.16	1.94	0.00	0.43	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	0.91	3.66	0.91	0.91	0.00	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	7.17	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	11.30	7.53	4.39	2.51	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	8.73	8.94	4.16	1.46	0.42	0.42	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	5.76	7.14	2.99	2.07	0.00	1.15	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	6.66	5.94	1.98	0.54	0.36	0.18	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	29.68	27.82	11.95	8.86	4.64	2.16	1.55
Burkitt's lymphoma cell line:RAJI	10476-106I8	32.84	41.22	19.33	12.11	3.49	3.49	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	12.47	13.43	15.35	3.84	0.96	1.60	0.64
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	10.34	41.37	20.68	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	9.58	12.40	7.89	0.00	0.00	4.51	2.25
CD14+ Monocytes, donor2	11305-117B9	11.14	10.21	7.24	0.37	1.11	2.97	1.11
CD14+ Monocytes, donor3	11381-118B4	12.07	9.22	10.76	0.44	1.10	4.61	1.10
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	20.95	13.59	5.38	2.55	1.70	0.00	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	15.92	14.40	10.99	3.03	0.76	0.76	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	21.70	13.15	6.90	4.93	0.66	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	17.20	6.50	1.88	1.16	0.58	1.88	0.58
CD14+ monocytes - mock treated, donor2	11873-125C1	22.63	6.64	3.02	0.60	1.21	0.60	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	20.37	9.48	2.61	1.18	1.42	1.42	0.95
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	8.20	4.35	1.51	0.33	1.00	1.34	1.51
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	16.28	3.59	0.83	0.28	1.10	1.66	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	14.88	3.97	1.24	0.50	0.74	3.22	0.99
CD14+ monocytes - treated with BCG, donor1	11860-125A6	8.42	3.13	0.59	0.39	0.20	1.96	0.59
CD14+ monocytes - treated with BCG, donor2	11870-125B7	7.66	2.31	1.96	0.53	0.18	2.85	0.53
CD14+ monocytes - treated with BCG, donor3	11880-125C8	16.76	3.92	1.09	0.87	0.87	6.09	1.31
CD14+ monocytes - treated with Candida, donor1	11868-125B5	6.09	2.58	1.87	0.00	0.70	4.21	1.40
CD14+ monocytes - treated with Candida, donor2	11878-125C6	6.86	4.22	1.58	0.53	1.06	2.64	2.11
CD14+ monocytes - treated with Candida, donor3	11888-125D7	9.98	1.11	1.11	0.00	0.00	3.33	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	12.49	3.72	1.78	0.30	0.89	2.08	0.89
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	16.56	2.79	0.40	0.60	0.80	1.00	0.60
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	24.98	6.25	2.50	1.25	1.67	1.04	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	8.69	2.75	0.00	0.00	0.46	3.20	0.69
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	14.02	2.71	1.36	0.00	0.90	2.26	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	10.48	3.93	0.44	0.87	0.87	2.18	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	15.60	2.69	1.34	0.00	0.81	2.96	0.54
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	13.61	4.19	1.74	0.17	1.40	2.44	0.52
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	24.83	5.05	2.52	1.26	1.26	2.52	1.68
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	7.53	1.47	0.18	0.18	0.18	2.39	1.47
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	13.74	2.11	0.70	1.06	0.35	4.23	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	9.65	2.19	1.32	1.32	1.75	2.19	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	5.23	2.44	0.70	0.00	0.87	2.96	1.05
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	7.43	2.60	1.49	0.00	0.74	5.58	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	13.58	4.74	2.59	0.22	0.86	4.74	1.29
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	3.69	1.64	1.64	0.00	0.41	2.46	1.23
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	10.43	3.01	1.85	0.46	0.46	4.40	1.16
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	12.53	2.55	1.62	0.70	0.46	4.18	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	28.55	13.08	5.45	1.31	2.18	0.65	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	22.64	14.55	6.93	0.23	0.69	1.62	0.92
CD14+CD16+ Monocytes, donor3	11912-125G4	23.39	13.00	7.15	1.08	1.30	1.52	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	25.38	13.08	7.79	1.56	1.87	1.25	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	22.70	11.53	5.94	0.87	1.57	1.22	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	47.05	22.30	8.70	2.23	2.23	1.78	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	25.01	14.54	8.93	1.28	1.02	3.32	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	20.42	10.32	5.05	0.88	0.88	3.07	0.66
CD14-CD16+ Monocytes, donor3	11911-125G3	27.79	17.48	10.11	2.53	0.42	2.74	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	8.13	12.19	38.61	2.03	0.00	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	3.39	15.59	32.54	4.07	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	5.18	18.64	33.14	5.18	0.00	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	8.53	21.32	18.12	3.20	0.00	2.13	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	4.82	23.05	38.60	8.58	0.00	1.07	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	7.02	25.97	40.01	1.40	0.00	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	4.71	23.53	37.65	1.57	1.57	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	7.91	21.09	43.50	1.32	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	9.04	23.84	51.78	1.64	0.00	1.64	0.00
CD19+ B Cells, donor2	11624-122B4	15.23	23.94	47.15	0.73	0.73	1.45	0.73
CD19+ B Cells, donor3	11705-123B4	5.05	22.72	54.02	2.52	0.50	2.02	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	26.67	30.30	12.93	7.68	0.40	4.04	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	21.17	18.78	9.19	5.99	0.80	4.39	1.20
CD34+ Progenitors, donor1	11545-120B6	9.04	13.05	28.11	4.02	0.00	7.03	0.00
CD34+ Progenitors, donor2	11625-122B5	10.67	15.17	25.28	2.81	1.12	2.81	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	13.53	15.03	14.28	2.25	1.13	1.13	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	23.00	20.07	18.72	4.51	2.03	0.23	0.23
CD4+ T Cells, donor1	11225-116C1	7.50	13.21	44.99	2.50	0.36	21.78	4.28
CD4+ T Cells, donor2	11306-117C1	3.67	15.31	51.44	2.45	0.00	12.86	6.12
CD4+ T Cells, donor3	11382-118B5	9.15	11.59	42.09	2.74	0.91	8.54	3.35
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	6.13	20.93	44.41	2.04	0.00	0.26	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	4.72	22.91	46.49	2.47	0.45	0.45	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	6.04	21.27	48.01	2.30	0.29	0.29	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	4.74	15.17	39.82	1.42	0.00	12.33	3.79
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	3.51	14.05	50.57	4.21	0.00	7.02	3.51
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	6.59	6.59	59.33	6.59	0.00	6.59	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	6.50	15.03	25.29	1.73	0.14	0.43	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	3.73	19.49	33.72	1.53	0.00	1.19	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	5.48	19.18	30.63	2.42	0.48	0.97	0.81
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	5.83	14.35	38.55	4.03	0.00	3.14	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	4.19	14.67	37.73	1.75	0.00	4.19	1.05
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	5.28	29.04	49.28	7.48	0.00	2.64	1.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	9.70	24.88	35.42	1.26	0.42	2.11	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	7.90	17.66	27.63	2.29	0.21	0.62	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	6.35	21.05	33.08	3.68	0.00	1.67	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	2.45	17.68	50.85	3.54	0.00	4.35	2.18
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	4.82	17.69	66.46	4.82	0.00	4.82	4.82
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	5.38	21.52	55.59	7.17	0.00	1.79	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	9.46	25.22	40.05	3.15	0.56	1.48	0.93
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	7.36	21.01	34.88	2.60	0.00	2.38	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	5.46	22.91	40.35	1.47	0.00	1.47	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	3.03	18.71	51.57	3.54	0.00	8.09	2.53
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	6.50	21.66	47.22	3.03	0.00	10.40	2.17
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	9.15	31.38	62.76	5.23	0.44	3.05	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	5.44	23.75	58.89	5.94	0.00	1.48	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	4.62	17.54	60.93	7.39	0.00	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	5.58	23.73	60.02	2.79	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	9.69	26.03	51.51	7.48	0.00	3.60	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	7.36	33.86	59.88	10.55	0.25	2.45	0.98
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	9.24	38.50	77.00	0.00	0.00	1.54	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	6.80	20.41	58.02	4.30	0.00	1.43	1.79
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	5.54	24.93	62.32	2.77	0.00	0.00	1.38
CD8+ T Cells, donor1	11226-116C2	12.11	22.92	41.58	1.64	0.00	9.17	1.31
CD8+ T Cells, donor2	11307-117C2	11.26	26.66	61.95	1.13	1.13	6.76	1.13
CD8+ T Cells, donor3	11383-118B6	9.85	28.28	46.71	1.01	0.25	9.34	3.53
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	20.65	14.91	3.67	0.69	0.69	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	16.77	17.25	3.83	1.68	0.48	0.00	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	21.61	20.52	3.28	0.27	1.92	0.27	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	23.12	15.91	2.70	1.20	0.60	0.30	1.20
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	21.36	11.52	3.84	0.24	0.48	0.48	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	20.01	12.73	4.32	0.23	0.91	0.23	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	29.12	18.69	3.69	1.30	0.65	0.22	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	27.90	18.42	5.26	1.05	1.05	0.53	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	24.86	17.12	3.75	0.94	1.88	0.47	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	29.58	19.62	7.55	0.60	1.21	0.91	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	28.47	25.27	2.91	0.87	1.45	0.29	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	27.44	21.58	4.00	0.27	0.80	0.80	0.53
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	28.45	8.32	3.50	0.44	1.31	0.00	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	35.52	8.65	1.82	0.00	2.28	0.00	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	30.58	8.20	1.49	0.00	1.49	0.75	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	20.53	11.16	4.68	1.08	1.44	0.00	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	15.25	11.51	3.74	0.29	1.15	0.29	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	16.50	10.13	6.13	0.71	0.71	0.47	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	32.64	24.40	9.19	0.00	0.00	0.95	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	29.53	19.07	5.23	0.62	1.85	0.00	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	28.85	19.24	8.01	0.96	0.96	0.64	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	29.83	19.51	4.59	1.91	1.15	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	25.62	14.19	4.73	0.00	1.58	0.39	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	28.74	15.88	6.05	0.76	2.27	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	54.60	14.45	2.41	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	51.06	10.49	1.40	0.70	1.40	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	55.10	19.03	3.01	1.00	0.00	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	18.28	16.45	3.66	0.00	0.00	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	8.89	9.88	4.45	0.99	1.48	0.00	0.49
Cardiac Myocyte, donor3	11686-122I3	12.84	11.89	5.47	3.58	0.84	0.21	0.32
Chondrocyte - de diff, donor1	11261-116G1	8.67	9.01	4.16	4.85	0.35	1.04	0.00
Chondrocyte - de diff, donor2	11338-117F6	8.17	4.62	3.20	1.42	0.36	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	7.74	5.46	4.89	0.68	0.80	0.11	0.11
Chondrocyte - re diff, donor2	11339-117F7	25.07	30.44	5.37	6.27	0.00	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	5.26	4.85	5.26	3.24	0.40	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	20.08	22.72	10.79	4.59	1.95	0.34	0.57
Ciliary Epithelial Cells, donor2	11323-117D9	11.54	14.11	6.20	2.78	1.28	0.43	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	11.50	13.81	5.40	4.69	0.97	0.53	0.44
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	17.88	11.74	9.63	2.75	0.37	1.19	1.01
Corneal Epithelial Cells, donor1	11526-119I5	2.63	3.95	2.42	1.10	0.44	0.00	0.22
Corneal Epithelial Cells, donor2	11606-120I4	4.55	4.55	1.14	2.28	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	6.65	2.81	1.28	1.28	0.77	0.26	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	32.36	13.70	6.27	1.16	1.98	0.66	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	30.59	13.25	4.10	0.63	2.21	0.63	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	37.96	17.25	6.90	0.00	10.35	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	23.00	12.53	3.56	0.43	1.73	0.43	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	11.27	14.69	30.41	0.34	1.02	3.76	1.71
Dendritic Cells - plasmacytoid, donor2	11309-117C4	7.83	15.02	36.56	1.31	0.00	4.57	3.92
Dendritic Cells - plasmacytoid, donor3	11385-118B8	9.68	17.91	43.56	2.90	0.48	6.29	3.87
Endothelial Cells - Aortic, donor0	11207-116A1	14.51	11.17	5.67	4.17	1.83	0.50	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	10.56	8.21	5.28	0.59	1.76	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	13.86	11.31	4.52	4.81	0.57	0.57	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	14.15	11.01	5.90	2.36	0.00	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	5.82	5.82	2.04	3.20	0.00	0.87	0.58
Endothelial Cells - Artery, donor2	11341-117F9	16.00	10.59	3.29	3.06	0.47	0.00	0.47
Endothelial Cells - Artery, donor3	11413-118E9	14.02	11.57	3.68	3.33	0.70	0.35	0.53
Endothelial Cells - Lymphatic, donor1	11236-116D3	8.20	6.87	5.32	3.55	0.66	0.22	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	14.00	14.00	6.69	2.74	1.22	0.91	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	15.79	10.71	8.18	4.51	0.00	0.28	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	6.54	3.27	1.49	1.49	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	8.85	9.89	2.60	1.56	1.56	0.00	0.52
Endothelial Cells - Microvascular, donor3	11414-118F1	3.40	3.26	1.56	1.42	0.28	0.43	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	21.21	17.21	4.40	6.00	0.40	1.20	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	4.72	6.29	1.05	0.52	0.00	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	28.08	25.47	10.56	11.06	1.62	0.99	0.50
Endothelial Cells - Umbilical vein, donor2	11324-117E1	15.43	11.73	7.60	5.65	0.65	0.22	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	13.43	17.95	9.53	6.84	0.61	0.98	0.24
Endothelial Cells - Vein, donor1	11267-116G7	7.96	6.83	9.10	2.28	1.14	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	8.38	9.78	2.79	2.79	0.00	1.40	0.00
Endothelial Cells - Vein, donor3	11416-118F3	8.95	7.54	5.18	4.40	0.63	0.31	0.47
Eosinophils, donor1	12244-129H3	15.25	76.23	15.25	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	28.05	23.10	6.60	1.65	0.00	4.95	0.00
Eosinophils, donor3	12246-129H5	3.57	3.57	3.57	7.13	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	3.18	2.93	0.73	0.49	0.00	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	6.24	2.08	0.00	4.16	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	8.21	7.80	6.57	0.82	0.82	0.41	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	3.72	4.05	2.08	0.66	0.11	0.22	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	6.07	6.50	4.01	1.63	0.43	0.22	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	15.65	13.22	8.25	2.91	1.09	0.85	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	20.47	15.01	11.87	4.91	1.09	1.91	0.96
Fibroblast - Aortic Adventitial, donor2	11326-117E3	8.12	6.33	2.85	1.58	0.32	0.11	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	22.40	17.92	12.12	8.96	0.26	0.26	1.58
Fibroblast - Aortic Adventitial, donor3	11401-118D6	8.64	9.63	6.64	2.99	1.00	0.33	0.33
Fibroblast - Cardiac, donor1	11268-116G8	15.88	8.62	4.54	1.81	0.45	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	8.34	6.06	3.03	1.52	2.27	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	3.94	2.84	3.31	0.95	0.47	0.47	0.16
Fibroblast - Cardiac, donor4	11452-119A3	25.76	19.10	9.40	0.91	0.91	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	14.85	13.07	5.71	2.54	1.14	0.25	1.02
Fibroblast - Cardiac, donor6	11460-119B2	19.71	16.37	6.67	3.64	0.61	0.76	0.91
Fibroblast - Choroid Plexus, donor1	11492-119E7	12.19	9.11	4.56	3.75	0.13	0.27	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	18.12	13.81	7.77	1.29	0.86	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	13.18	13.18	7.32	1.46	0.00	2.93	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	9.69	6.00	2.08	1.85	0.69	0.00	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	19.50	13.23	7.80	1.02	1.36	0.34	0.17
Fibroblast - Dermal, donor1	11269-116G9	15.03	14.79	7.51	1.17	1.17	0.00	0.23
Fibroblast - Dermal, donor2	11346-117G5	10.85	14.62	6.13	3.30	0.47	0.94	1.42
Fibroblast - Dermal, donor3	11418-118F5	11.48	11.12	5.44	1.21	1.45	0.24	0.12
Fibroblast - Dermal, donor4	11450-119A1	23.97	25.77	9.27	4.97	1.13	0.57	0.57
Fibroblast - Dermal, donor5	11454-119A5	28.44	31.58	9.07	6.28	1.40	0.17	1.05
Fibroblast - Dermal, donor6	11458-119A9	29.72	31.51	11.04	6.01	1.46	0.49	0.65
Fibroblast - Gingival, donor1	11237-116D4	19.57	18.32	8.33	2.71	1.04	0.21	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	16.51	17.55	9.69	2.36	1.05	0.26	0.26
Fibroblast - Gingival, donor2	11318-117D4	21.09	19.24	7.12	3.82	0.40	0.66	0.13
Fibroblast - Gingival, donor3	11394-118C8	14.79	12.38	7.25	2.22	0.87	0.48	0.29
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	13.51	11.43	4.16	1.04	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	8.46	7.22	3.17	1.06	0.35	0.18	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	25.72	20.73	7.48	2.81	1.09	0.78	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	24.21	17.58	8.52	2.43	0.81	0.81	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	8.12	8.82	5.29	5.29	0.35	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	15.79	20.47	9.65	3.36	0.88	0.58	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	20.59	21.27	9.14	2.18	0.95	0.55	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	25.01	22.27	8.23	4.50	1.43	0.77	1.10
Fibroblast - Gingival, donor9 (control)	11927-125I1	15.70	12.33	9.24	0.88	1.17	0.73	0.00
Fibroblast - Lung, donor1	11270-116H1	6.80	6.80	6.80	0.00	1.36	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	23.87	23.87	2.98	1.49	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	13.51	12.45	4.43	1.90	1.27	0.21	0.21
Fibroblast - Lymphatic, donor1	11506-119G3	11.66	9.16	2.50	1.67	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	1.40	2.80	1.40	2.80	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	1.96	1.68	1.40	0.28	0.00	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	15.43	12.59	4.87	1.62	1.62	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	0.00	0.00	3.99	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	5.96	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	25.02	23.28	10.67	3.69	1.75	1.16	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	28.97	26.85	11.83	6.67	1.21	0.76	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	32.74	29.99	11.32	7.34	1.53	1.53	0.92
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	14.50	14.12	8.01	3.05	0.38	0.76	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	9.45	6.21	6.21	1.35	1.08	0.54	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	8.00	8.70	4.29	2.20	0.58	0.35	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	17.57	14.70	4.86	3.09	0.55	0.99	0.44
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	8.53	5.89	2.84	1.02	0.61	1.02	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	8.69	12.03	3.34	1.34	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	12.26	12.65	2.37	1.98	0.40	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	33.74	27.19	16.67	7.54	0.99	1.79	0.99
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	12.61	9.95	6.93	1.78	0.71	0.18	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	20.10	14.98	6.31	1.58	0.59	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	25.57	25.27	10.83	7.22	1.50	0.60	1.20
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	21.81	18.14	8.31	2.81	1.62	0.11	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	25.56	19.99	12.15	6.33	1.52	0.51	1.52
Fibroblast - skin normal, donor1	11553-120C5	14.11	12.14	8.53	1.48	0.66	0.49	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	32.68	31.08	20.85	5.41	1.00	1.60	1.40
Fibroblast - skin normal, donor2	11561-120D4	18.38	16.98	6.73	1.91	0.60	0.50	0.80
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	37.78	32.04	20.85	6.35	0.91	1.51	1.81
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	15.99	13.42	7.79	1.74	0.83	0.50	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	18.80	15.56	8.72	1.54	0.51	0.51	0.34
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	26.60	17.08	15.44	5.91	0.00	0.66	1.31
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	16.94	14.70	6.82	3.20	0.32	0.85	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	17.54	16.19	6.24	2.19	0.51	0.51	0.67
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	10.51	7.84	4.23	0.94	0.78	0.00	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	16.56	10.46	11.33	6.97	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	13.18	12.48	4.51	3.29	0.35	1.91	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	21.34	15.35	4.42	3.12	1.30	0.26	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	16.10	12.01	7.41	2.56	0.51	1.28	1.02
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	16.84	13.01	2.30	7.66	0.77	0.77	2.30
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	12.76	14.04	5.74	6.38	0.64	0.00	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	15.97	10.27	5.42	17.69	2.85	7.13	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	12.13	9.10	4.14	14.89	0.28	1.10	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	13.47	13.93	2.97	9.36	0.46	0.68	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	11.10	12.68	4.76	13.87	2.38	4.76	2.38
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	7.14	10.57	3.70	10.57	0.79	1.59	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	18.26	13.70	5.22	8.48	2.28	1.63	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	8.84	7.08	2.21	24.32	0.88	2.65	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	14.41	10.18	4.24	8.62	2.54	1.41	0.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	14.41	13.05	5.91	7.39	1.85	1.23	0.62
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	13.97	11.55	3.76	8.60	1.34	2.69	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	15.24	10.16	4.58	9.54	2.11	0.87	0.50
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	12.04	9.69	4.98	10.11	1.66	1.52	1.11
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	12.20	5.69	3.86	5.08	0.41	0.61	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	15.06	10.27	3.42	5.48	0.23	0.91	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	13.45	10.09	4.24	6.60	2.24	0.62	0.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	14.43	7.43	2.62	5.03	1.09	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	14.18	13.30	5.61	2.95	1.48	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	18.76	13.03	5.25	6.36	1.27	1.27	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	11.39	7.37	3.13	6.03	0.89	0.89	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	19.36	14.72	5.24	2.62	1.81	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	20.53	14.08	7.46	5.94	2.54	1.19	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	25.45	16.85	6.74	5.85	2.13	1.51	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	24.45	18.94	7.18	5.62	2.19	1.14	0.73
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	25.27	18.27	4.78	3.93	1.37	0.85	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	16.27	15.93	5.53	5.31	2.21	1.00	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	26.54	16.22	3.66	4.91	1.41	1.58	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	27.77	23.07	6.74	5.10	1.02	1.63	0.61
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	16.50	13.82	6.60	3.71	1.65	1.24	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	16.37	12.34	6.57	5.53	2.31	0.81	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	18.18	15.01	4.84	5.00	1.83	0.83	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	16.97	12.56	3.31	3.09	3.31	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	17.59	13.41	6.76	4.43	1.72	0.37	0.25
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	20.10	14.43	4.21	5.19	0.81	1.30	0.16
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	13.15	10.58	3.21	3.21	1.28	0.96	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	17.15	11.09	4.64	3.60	1.61	0.95	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	17.72	15.34	5.06	3.01	0.95	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	15.20	11.25	3.95	3.34	1.52	0.61	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	18.40	15.47	5.75	4.70	1.46	0.73	0.73
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	16.69	14.49	3.51	1.98	1.54	0.88	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	15.15	12.34	5.61	3.37	1.68	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	18.70	17.31	6.02	2.78	1.20	0.56	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	26.21	14.17	4.55	3.48	1.60	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	20.81	14.54	7.34	2.45	1.53	0.77	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	19.30	12.31	6.09	2.46	1.68	0.65	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	15.72	10.84	5.96	2.71	1.08	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	16.78	15.30	7.01	1.84	1.84	0.37	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	17.11	16.45	6.36	1.32	1.10	0.88	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	20.83	4.96	8.93	3.97	0.99	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	20.58	15.04	6.33	3.17	0.66	0.53	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	12.11	11.50	7.67	2.22	0.61	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	17.28	20.84	8.13	2.29	1.78	0.00	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	25.88	20.11	4.98	17.92	2.39	4.78	1.99
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	10.94	12.79	4.16	10.32	1.85	2.16	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	21.28	19.03	4.50	14.73	4.09	1.84	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	18.46	13.46	6.57	10.33	1.56	1.56	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	14.98	14.13	5.09	8.48	1.70	3.11	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	18.45	15.68	8.30	12.91	0.92	2.31	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	24.75	17.32	7.42	12.37	2.47	2.47	4.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	27.46	20.89	6.96	5.03	1.55	1.16	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	28.88	20.86	3.21	14.44	1.60	4.81	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	27.82	13.91	5.22	12.17	0.00	0.00	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	22.46	14.32	2.28	6.51	0.65	1.30	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	20.59	17.30	9.47	8.65	0.82	1.24	2.06
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	10.00	13.33	3.33	3.33	6.66	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	17.62	19.85	6.15	7.55	0.84	0.28	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	25.49	18.30	3.92	8.82	1.63	0.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	13.42	15.10	3.36	14.26	1.68	0.84	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	22.27	13.68	4.77	7.63	1.59	2.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	20.72	17.66	4.76	10.53	1.36	1.70	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	18.79	10.44	6.26	4.18	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	21.19	13.17	3.44	9.74	0.57	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	15.39	13.02	3.85	5.92	1.78	1.18	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	13.55	6.78	6.78	6.78	0.00	5.08	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	31.48	15.33	7.04	5.80	2.49	1.66	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	29.23	15.88	4.14	8.51	2.53	1.38	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	15.81	21.07	5.27	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	19.61	14.22	4.61	5.77	1.15	1.15	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	17.28	11.41	2.61	6.19	2.28	0.65	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	18.73	8.69	2.01	5.35	3.34	1.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	12.71	9.63	2.31	5.78	1.93	0.39	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	31.84	13.69	3.42	9.59	1.71	0.00	1.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	12.42	19.88	9.94	7.45	2.48	4.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	16.04	10.85	3.77	8.97	1.42	0.47	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	13.28	9.05	3.62	8.45	1.21	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	12.72	12.21	3.05	10.68	1.53	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	14.36	12.36	3.59	7.58	1.20	0.40	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	18.25	14.31	5.43	7.89	3.45	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	15.35	9.44	2.36	7.08	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	16.34	7.58	4.67	8.75	2.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	12.29	14.48	2.19	6.14	0.44	0.44	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	19.50	9.32	2.54	9.32	1.70	0.85	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	16.12	9.55	3.58	7.76	1.79	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	14.07	7.76	2.91	1.94	1.46	0.49	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	14.84	7.99	6.85	2.28	1.14	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	3.74	6.24	4.16	1.66	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	10.12	11.24	5.62	2.25	0.00	2.25	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	6.66	5.71	3.81	0.63	0.63	0.95	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	4.18	7.10	4.18	1.25	0.42	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	29.71	16.83	4.41	3.37	1.97	0.23	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	36.80	19.92	4.56	3.54	1.69	0.68	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	30.71	17.06	3.41	2.96	0.91	0.46	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	28.86	15.19	5.25	3.17	1.86	0.44	0.66
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	35.03	17.19	6.02	2.79	1.72	0.64	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	28.20	16.58	3.66	3.44	0.65	0.65	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	25.90	12.83	5.11	1.62	1.62	0.37	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	30.02	14.41	3.95	1.72	1.37	1.03	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	28.51	11.21	1.92	2.24	0.96	0.00	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	2.80	7.28	1.68	1.12	0.56	0.00	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	2.60	3.03	0.43	0.87	0.00	0.43	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	15.86	7.93	0.00	5.29	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	3.17	5.64	2.12	0.71	0.00	0.35	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	5.09	2.91	3.63	0.73	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	10.14	11.36	4.02	2.97	0.52	0.87	0.35
Hepatocyte, donor1	11523-119I2	27.84	7.26	6.05	3.63	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	16.16	7.54	3.23	3.23	1.08	0.00	0.00
Hepatocyte, donor3	11684-122I1	13.50	8.59	3.68	5.52	1.23	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	12.40	22.84	37.20	5.87	0.65	7.83	5.22
Intestinal epithelial cells (polarized), donor1	11246-116E4	50.51	24.99	5.77	5.24	3.85	0.87	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	13.86	11.66	4.12	3.29	0.27	0.27	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	54.13	31.84	3.18	0.00	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	6.68	6.68	20.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	27.08	27.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	31.84	18.00	8.31	6.92	0.00	4.15	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	37.54	5.01	0.00	10.01	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	47.47	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	43.57	17.94	10.25	10.25	2.56	5.13	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	36.57	9.14	0.00	9.14	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	21.12	19.49	6.50	3.25	0.00	3.25	4.87
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	31.68	20.01	1.67	10.00	0.00	1.67	3.33
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	36.31	21.78	3.63	0.00	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	25.15	18.53	10.59	7.94	1.32	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	25.50	19.96	6.65	11.09	1.11	2.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	41.91	10.48	10.48	5.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	30.86	19.53	11.34	3.15	0.00	0.63	1.26
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	27.84	35.57	9.28	7.73	1.55	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	43.90	14.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	32.95	25.20	7.75	10.34	0.65	1.94	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	48.30	25.76	4.83	9.66	1.61	0.00	4.83
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	83.64	23.90	11.95	11.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	40.74	28.52	13.04	13.04	0.81	5.70	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	30.23	20.15	7.98	5.46	1.26	2.94	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	57.49	14.37	14.37	0.00	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	30.54	26.52	6.43	5.63	0.80	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	24.93	26.78	7.39	2.77	0.00	1.85	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	60.32	60.32	45.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	21.71	21.24	8.50	4.72	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	27.21	24.49	4.53	6.35	1.81	0.91	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	88.45	44.23	29.48	14.74	0.00	0.00	14.74
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	34.44	33.36	12.91	6.46	0.00	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	29.22	35.57	7.62	6.35	0.00	3.81	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	65.72	32.86	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	35.07	29.97	10.20	6.38	0.00	1.28	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	40.10	29.16	7.29	3.65	0.00	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	31.61	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	44.99	31.42	8.57	6.43	1.43	2.14	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	39.82	59.73	19.91	23.23	3.32	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	20.85	62.55	41.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	20.99	22.22	5.86	6.17	1.23	1.54	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	36.88	33.36	21.07	17.56	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	25.15	59.72	6.29	15.72	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	27.12	36.86	10.43	13.91	0.00	2.78	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	33.20	22.13	11.07	15.49	2.21	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	19.45	22.69	9.73	12.97	0.00	3.24	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	28.77	15.69	10.46	5.23	0.87	1.74	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	33.75	22.50	11.25	11.25	2.25	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	31.36	31.36	13.94	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	34.14	16.00	10.67	1.07	0.00	2.13	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	26.32	29.09	2.77	16.63	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	37.04	37.04	0.00	14.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	23.93	17.49	7.36	12.89	0.00	3.68	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	33.28	18.15	12.10	6.05	0.00	0.00	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	62.09	18.63	12.42	6.21	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	16.92	8.46	5.29	4.23	1.06	0.00	1.06
Keratinocyte - epidermal, donor1	11272-116H3	10.28	11.26	4.41	1.63	0.33	0.49	0.33
Keratinocyte - epidermal, donor2	11349-117G8	8.78	4.69	2.34	1.17	0.59	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	10.60	12.49	5.87	4.07	0.57	0.47	0.38
Keratinocyte - oral, donor1	11251-116E9	17.48	17.14	5.22	3.18	1.48	0.68	0.34
Keratocytes, donor1	11527-119I6	5.50	4.13	3.09	1.38	0.00	0.69	0.00
Keratocytes, donor2	11607-120I5	7.03	5.86	3.52	1.17	0.00	0.00	0.00
Keratocytes, donor3	11688-122I5	5.14	5.14	4.94	3.75	0.99	0.40	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	28.57	6.59	4.40	10.99	0.00	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	7.55	16.18	4.31	4.31	2.16	2.16	0.00
Lens Epithelial Cells, donor2	11609-120I7	14.53	11.65	7.96	4.04	0.58	0.69	0.12
Lens Epithelial Cells, donor3	11690-122I7	14.53	13.02	7.47	3.23	1.11	0.61	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	8.89	7.83	2.96	2.96	0.47	0.59	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	6.14	4.74	2.79	1.12	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	10.23	6.45	4.56	1.73	0.31	0.31	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	5.38	6.45	3.23	0.54	1.08	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	6.30	6.30	1.26	1.58	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	3.56	3.67	1.62	1.83	0.32	0.11	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	12.31	6.16	1.64	2.05	0.00	0.00	0.41
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	2.78	2.28	0.76	1.26	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	4.79	4.22	1.41	0.99	0.00	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	8.70	3.96	2.77	0.40	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	4.85	5.23	1.74	3.10	0.00	0.19	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	2.78	2.22	1.30	0.93	0.19	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	8.36	3.83	1.74	1.39	0.70	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	4.77	2.15	1.67	0.72	0.48	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	4.26	4.26	1.51	0.96	0.27	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	4.93	7.70	2.46	2.46	0.00	0.62	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	4.36	4.05	1.25	2.18	0.62	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	3.84	4.03	1.83	0.55	0.00	0.55	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	6.58	4.94	3.62	0.33	0.33	0.33	0.66
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	4.69	2.93	1.76	0.29	0.29	0.00	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	3.73	3.24	1.24	0.50	0.00	0.75	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	7.27	7.27	1.45	0.97	0.00	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	7.54	6.19	1.08	0.81	0.00	0.27	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	6.51	4.69	0.91	0.91	0.15	0.61	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	6.74	4.67	0.52	2.07	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	7.96	7.54	2.93	1.68	0.00	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	4.81	4.96	1.20	0.90	0.45	0.45	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	6.19	8.25	6.19	2.06	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	5.08	5.08	2.26	1.13	0.00	0.38	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	3.50	2.76	1.38	0.64	0.00	0.21	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	5.81	8.24	3.39	1.94	1.45	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	4.96	4.63	1.65	1.32	0.33	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	3.10	2.85	0.99	1.12	0.12	0.25	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	10.00	8.14	2.96	3.70	0.74	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	4.69	3.21	3.21	1.48	0.25	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	4.12	2.34	2.47	1.10	0.14	0.41	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	8.68	8.36	2.57	0.64	0.64	0.32	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	6.70	5.78	1.22	0.61	0.61	0.91	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	7.00	3.92	2.94	1.96	0.56	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	6.76	9.60	2.49	2.49	0.71	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	4.36	1.45	1.45	0.97	0.00	0.48	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	2.65	2.33	0.93	0.78	0.16	0.16	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	6.45	2.86	0.72	1.43	0.36	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	4.25	4.90	0.65	1.31	0.65	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	2.83	1.88	0.71	0.00	0.24	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	8.79	8.04	1.86	1.49	0.50	0.37	0.50
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	2.31	2.82	1.02	1.02	0.26	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	3.28	4.18	1.19	0.60	0.30	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	31.72	13.60	4.53	4.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	27.62	13.04	6.14	5.37	0.00	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	23.01	11.13	4.45	0.74	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	28.35	19.46	6.77	3.39	0.85	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	26.02	10.55	4.92	3.52	0.70	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	24.28	14.94	4.67	1.87	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	26.28	12.37	3.09	1.55	0.00	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	19.03	14.27	5.95	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	22.17	10.86	5.20	2.49	1.36	0.23	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	24.43	12.80	3.49	0.87	0.58	0.58	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	29.71	14.41	3.15	1.80	2.25	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	27.10	16.26	6.10	1.90	1.49	0.81	0.54
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	25.16	13.87	4.62	2.05	2.57	0.51	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	21.17	13.41	7.06	1.76	2.12	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	25.32	14.66	6.66	2.67	2.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	19.36	15.28	8.15	3.57	1.02	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	23.21	12.01	5.34	2.67	0.80	0.27	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	22.11	14.93	6.24	2.65	2.27	0.19	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	34.36	19.63	5.52	0.61	1.23	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	27.72	17.94	3.26	3.26	1.63	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	21.24	12.70	6.87	1.67	1.04	0.62	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	23.82	15.13	5.32	2.52	1.12	0.28	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	20.61	18.55	5.15	6.18	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	17.71	12.19	7.26	3.19	0.29	1.16	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	20.63	13.75	6.28	1.49	0.60	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	26.56	16.60	2.77	1.11	0.55	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	31.46	18.03	5.30	1.77	1.41	0.35	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	27.29	18.07	8.11	0.74	0.74	0.74	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	20.72	11.51	4.61	1.15	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	26.86	19.96	6.52	3.84	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	27.17	20.95	6.23	1.13	0.00	1.13	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	19.69	14.77	6.56	1.64	0.82	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	26.21	15.82	5.42	2.71	0.90	0.45	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	23.70	12.93	7.18	0.72	1.44	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	24.65	20.17	5.23	0.00	0.75	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	26.01	17.84	5.95	1.86	1.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	29.72	15.08	3.02	2.58	0.43	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	16.27	19.69	4.28	4.28	3.43	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	22.99	15.66	8.66	2.33	1.00	1.00	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	31.98	20.51	9.05	1.81	0.60	1.21	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	17.06	15.64	2.13	2.84	2.13	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	18.56	13.40	5.84	2.41	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	36.50	17.18	5.37	2.68	0.54	1.07	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	21.55	14.81	6.06	2.02	1.35	2.69	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	25.93	17.78	5.93	2.22	1.11	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	32.56	16.28	6.98	2.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	20.10	20.10	9.52	4.23	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	23.21	17.21	4.40	2.80	0.40	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	31.98	23.26	11.63	1.45	0.73	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	28.36	23.76	6.13	1.53	1.53	0.77	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	26.14	14.80	8.39	1.48	2.47	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	30.11	19.76	12.23	0.94	0.00	0.94	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	28.16	11.56	6.54	3.02	1.01	1.01	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	31.09	23.43	9.91	2.25	2.25	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	36.14	25.82	3.44	1.72	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	26.72	20.49	5.79	3.12	1.34	0.45	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	28.54	18.77	7.82	3.13	1.56	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	31.67	19.79	4.62	1.98	1.98	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	31.65	20.24	5.19	3.63	2.08	1.04	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	28.00	11.81	7.44	4.81	0.00	1.31	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	32.43	10.62	6.15	1.68	1.12	1.12	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	26.94	14.57	7.51	2.21	1.77	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	26.61	16.59	7.33	2.31	1.93	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	31.90	16.20	9.62	0.00	3.54	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	26.91	18.26	6.25	4.33	1.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	29.82	19.88	9.94	3.18	1.19	0.80	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	30.99	16.41	10.33	3.04	1.22	0.61	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	29.74	19.37	5.53	2.08	0.69	0.00	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	25.08	19.00	7.60	3.04	0.38	0.38	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	28.40	19.11	5.16	1.55	1.55	0.52	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	30.23	13.91	6.65	3.63	0.60	1.21	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	24.08	15.85	6.65	0.95	0.63	0.00	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	29.32	25.06	5.33	2.13	2.13	1.07	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	29.31	19.54	8.05	5.17	1.72	1.15	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	22.11	23.65	8.74	1.54	2.06	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	38.20	26.88	7.07	2.12	1.41	0.71	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	24.97	18.73	6.24	5.67	1.70	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	28.29	15.39	6.66	1.66	0.83	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	34.45	19.58	4.70	3.13	0.00	0.78	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	24.64	13.36	6.26	4.18	0.42	0.00	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	20.91	13.47	10.69	2.79	0.46	0.00	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	31.45	21.41	4.68	2.68	0.67	0.00	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	25.13	13.37	11.23	3.74	0.53	1.07	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	22.23	13.34	6.87	3.64	1.62	1.62	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	32.12	19.27	6.42	1.84	0.92	0.92	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	24.01	23.12	9.78	2.67	1.78	1.78	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	19.38	15.39	8.55	5.13	1.14	0.00	0.57
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	34.51	19.17	4.60	2.30	0.77	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	32.83	17.51	9.30	2.74	0.55	0.00	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	28.51	20.49	8.91	2.67	1.78	0.89	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	30.93	22.10	8.58	3.90	1.04	0.52	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	36.47	25.86	8.62	9.95	3.32	0.66	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	31.18	16.63	10.39	0.00	2.08	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	14.13	10.71	5.70	1.60	1.14	0.68	0.00
Macrophage - monocyte derived, donor2	11313-117C8	19.82	10.09	2.57	1.84	1.28	0.18	0.37
Macrophage - monocyte derived, donor3	11389-118C3	16.65	9.57	5.24	2.75	0.92	0.66	0.66
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	12.21	5.84	3.19	0.53	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	20.76	14.10	6.18	2.54	0.63	0.79	0.79
Mallassez-derived cells, donor3	11930-125I4	27.80	22.10	5.56	2.92	0.28	0.28	0.14
Mammary Epithelial Cell, donor1	11273-116H4	14.15	13.75	5.18	3.69	1.59	0.20	0.30
Mammary Epithelial Cell, donor2	11350-117G9	21.72	17.95	5.79	3.19	2.61	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	7.23	9.48	3.74	2.99	0.75	0.00	0.25
Mast cell - stimulated, donor1	11487-119E2	62.37	33.22	12.20	2.71	4.07	0.68	0.00
Mast cell, donor1	11563-120D6	23.03	16.87	8.11	2.49	0.97	0.32	0.11
Mast cell, donor2	11565-120D8	21.10	14.56	11.29	1.49	1.78	0.89	1.19
Mast cell, donor3	11566-120D9	22.06	20.94	11.93	2.70	1.35	2.25	0.68
Mast cell, donor4	11567-120E1	14.36	10.99	5.85	1.77	1.42	0.89	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	38.59	36.15	12.53	2.00	2.11	0.55	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	49.03	39.11	4.67	1.75	2.92	0.58	0.00
Mast cell, expanded, donor5	11939-126A4	25.01	28.91	9.98	1.61	0.92	0.23	0.23
Mast cell, expanded, donor8	11941-126A6	31.97	31.63	7.87	1.51	1.34	0.50	0.00
Melanocyte - dark, donor1	11502-119F8	10.94	11.84	4.28	3.48	0.30	0.20	0.50
Melanocyte - dark, donor2	11582-120F7	18.69	9.34	3.46	2.42	0.69	0.35	1.04
Melanocyte - dark, donor3	11663-122F7	28.32	22.67	6.59	1.96	0.87	0.58	0.22
Melanocyte - light, donor1	11274-116H5	10.81	7.76	1.41	0.71	0.71	0.24	0.24
Melanocyte - light, donor2	11351-117H1	7.51	8.87	1.36	2.05	0.00	0.00	0.68
Melanocyte - light, donor3	11423-118G1	3.47	6.94	3.47	0.87	0.87	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	19.47	23.32	6.04	4.37	0.52	0.73	0.42
Melanocyte, donor2 (MC+2)	12739-135I3	18.29	25.01	4.57	1.08	1.08	0.00	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	18.21	15.27	6.16	2.14	0.54	0.54	0.00
Meningeal Cells, donor1	11493-119E8	13.52	13.03	5.46	5.33	0.62	0.87	0.50
Meningeal Cells, donor2	11573-120E7	7.48	14.97	3.96	5.28	1.32	1.76	2.20
Meningeal Cells, donor3	11654-122E7	30.07	32.19	10.19	6.11	1.14	0.90	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	14.26	18.82	9.12	2.00	1.14	0.29	1.43
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	11.77	9.96	5.94	1.71	0.40	0.40	0.40
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	1.31	1.31	2.63	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	3.92	2.62	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	16.50	12.92	4.31	0.00	0.72	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	9.74	6.56	4.24	3.39	1.06	0.64	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	15.08	11.56	6.03	2.51	0.50	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	6.59	9.01	3.08	1.76	0.22	0.44	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	5.11	10.96	0.73	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	5.93	10.23	3.68	1.64	0.20	0.20	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	10.39	9.56	5.26	2.49	0.83	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	4.09	2.23	1.49	0.37	0.37	0.74	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	15.79	11.71	4.21	0.53	1.32	0.13	0.92
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	6.83	5.04	2.37	0.30	0.00	0.30	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	11.68	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	8.97	3.84	3.20	2.56	0.64	0.64	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	23.39	16.66	6.38	1.06	1.42	1.42	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	14.70	8.44	5.63	1.56	0.63	0.94	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	10.89	13.06	2.90	2.90	0.00	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	7.16	5.83	4.51	2.65	0.53	0.27	0.80
Mesothelial Cells, donor2	12156-128G5	7.51	7.01	5.51	2.50	0.00	0.00	0.50
Mesothelial Cells, donor3	11402-118D7	5.85	6.87	4.34	1.81	0.07	0.51	0.29
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	2.70	2.70	0.00	2.70	1.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	16.50	9.11	7.14	1.48	0.49	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	16.20	10.89	5.30	0.88	0.88	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	17.29	3.46	0.00	0.00	3.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	14.88	8.68	4.34	0.00	0.62	0.00	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	12.86	9.33	3.11	0.41	1.04	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	4.63	11.58	2.32	0.00	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	13.51	7.51	3.75	0.50	0.25	1.00	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	15.36	7.91	11.17	0.00	0.93	0.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	19.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	11.99	6.91	3.86	0.61	0.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	12.27	8.32	4.36	0.00	0.00	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	7.96	3.54	1.77	0.00	0.00	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	12.16	6.84	2.28	1.52	1.14	0.76	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	2.63	3.95	5.26	0.00	0.00	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	8.91	3.40	2.76	0.42	0.00	0.42	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	11.05	2.76	1.84	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	6.86	2.68	4.77	0.89	0.00	0.89	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	6.71	1.68	1.68	0.00	0.00	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	9.03	4.52	1.51	0.50	0.25	0.50	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	10.22	8.32	3.57	0.71	0.48	0.71	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	6.63	7.74	4.42	0.55	0.55	0.00	1.11
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	7.60	4.84	1.15	0.23	0.46	0.23	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	8.83	3.16	3.16	0.63	0.63	0.42	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	7.95	4.89	2.85	0.41	0.61	0.20	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	9.01	5.36	2.36	0.43	0.64	0.64	0.64
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	9.11	4.45	2.89	0.67	0.44	0.89	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	5.69	4.38	1.31	0.00	0.88	0.66	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	7.60	5.58	1.52	0.00	0.00	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	4.97	4.97	0.00	0.00	1.66	0.00	1.66
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	7.34	4.89	1.63	1.09	0.54	1.36	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	7.94	7.35	5.59	0.29	1.18	0.88	0.59
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	5.45	4.36	2.18	0.00	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	6.73	4.81	1.44	0.96	0.96	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	9.61	4.40	4.40	1.20	0.40	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	5.48	8.23	4.11	1.37	0.00	0.00	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	9.51	3.50	1.00	0.00	0.00	1.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	26.95	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	0.00	4.08	0.00	0.00	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	14.89	9.63	3.07	1.31	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	7.73	2.21	4.41	1.10	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	10.89	8.97	3.20	0.00	1.28	1.28	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	11.65	6.94	3.72	0.99	0.50	1.24	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	6.96	4.87	3.48	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	11.05	2.21	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	10.60	6.15	2.74	1.03	0.68	0.34	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	10.07	10.07	5.25	0.88	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	8.88	5.68	3.20	1.42	0.71	0.36	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	14.31	9.82	1.96	0.28	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	16.21	13.30	7.07	0.83	0.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	9.91	5.24	4.66	0.58	0.58	0.00	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	11.16	5.73	4.83	1.21	0.60	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	17.11	5.43	6.26	2.09	1.25	0.00	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	7.22	7.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	14.78	5.54	5.54	1.85	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	16.50	11.95	10.24	2.85	0.57	2.28	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	11.05	7.60	3.73	0.83	0.55	0.14	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	15.03	7.52	2.07	0.78	0.00	0.00	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	20.16	8.15	5.15	0.86	1.29	0.86	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	10.16	4.45	5.08	0.64	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	14.15	7.47	2.94	0.53	0.53	0.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	14.37	10.18	3.29	1.50	0.90	0.30	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	7.77	6.50	2.54	0.57	0.28	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	14.97	6.69	3.50	0.96	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	18.13	8.18	5.09	0.66	0.88	0.44	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	9.86	10.62	4.17	0.76	0.38	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	15.06	6.53	5.68	1.99	0.00	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	16.22	10.57	2.95	0.49	0.49	0.74	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	11.73	5.87	4.56	1.30	0.00	0.00	1.30
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	11.17	8.23	4.70	2.65	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	11.82	8.36	4.90	0.86	0.58	0.86	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	9.89	6.18	3.30	1.65	0.00	0.41	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	11.91	8.64	5.36	2.08	0.00	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	15.07	11.30	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	8.91	7.13	1.78	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	16.76	6.57	3.29	1.64	0.99	0.00	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	11.57	5.26	2.10	0.00	2.10	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	13.64	7.91	4.35	0.20	0.79	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	13.97	9.31	4.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	8.64	9.01	5.63	0.75	1.50	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	10.65	5.06	1.33	0.27	1.60	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	16.06	8.82	3.73	1.02	0.57	0.34	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	8.10	4.42	2.21	1.47	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	14.29	7.33	3.30	1.83	0.73	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	18.67	6.22	4.67	1.56	1.56	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	9.62	2.14	2.67	0.53	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	7.73	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	16.16	3.03	2.02	1.01	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	8.01	7.17	2.95	0.84	0.42	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	27.24	0.00	0.00	0.00	0.00	2.72	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	2.54	0.64	0.64	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	4.86	0.81	2.43	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	27.19	3.02	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	119.91	17.13	11.42	0.00	5.71	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	137.02	13.05	3.26	0.00	9.79	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	42.77	4.75	0.00	4.75	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	188.24	0.00	12.55	12.55	0.00	0.00	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	14.65	13.57	4.31	2.80	0.43	0.22	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	15.68	12.54	11.50	1.57	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	4.67	10.68	8.01	3.34	0.67	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	6.26	7.10	5.84	1.67	0.83	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	25.86	18.82	6.65	2.09	1.33	1.14	0.76
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	19.15	15.96	14.36	0.00	0.00	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	5.44	5.44	5.44	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	53.29	23.89	9.19	7.35	7.35	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	4.19	9.21	5.86	0.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	7.21	6.51	6.51	1.86	0.70	0.70	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	7.84	10.27	8.38	2.16	0.27	0.27	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	15.14	14.93	6.73	1.26	1.26	0.21	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	77.94	33.40	22.27	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	7.45	9.93	7.94	1.49	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	10.56	4.87	4.60	0.27	0.27	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	8.16	5.44	4.99	0.23	0.23	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	6.37	7.68	8.33	1.63	0.16	0.00	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	18.04	9.66	8.38	1.82	0.73	0.55	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	5.30	6.37	3.71	2.12	0.53	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	4.80	5.40	4.20	1.80	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	19.69	6.89	6.56	0.00	0.66	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	3.74	5.37	5.85	1.30	0.16	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	12.70	8.11	10.23	1.59	0.71	0.00	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	7.74	5.63	7.03	0.70	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	6.90	5.52	9.65	1.84	0.46	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	7.07	8.03	5.46	2.89	0.32	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	20.69	10.69	7.59	2.07	1.38	0.69	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	96.08	40.46	25.28	10.11	2.53	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	14.26	8.02	9.36	2.01	0.89	0.45	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	8.04	8.89	6.35	0.42	1.27	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	4.75	5.93	6.65	1.66	0.71	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	6.87	11.16	8.58	2.58	0.43	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	54.17	27.08	9.03	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	7.66	9.66	8.00	2.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	11.72	13.08	2.25	1.80	0.00	0.45	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	6.75	4.36	5.95	1.98	1.98	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	3.71	8.36	8.36	1.86	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	7.19	7.19	3.78	1.51	0.76	1.14	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	5.54	8.15	6.52	0.98	0.00	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	1.31	6.97	8.28	3.05	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	16.28	6.78	7.69	0.90	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7.94	9.70	6.17	0.00	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	4.65	5.98	7.31	3.99	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	7.44	10.42	6.45	1.98	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	4.59	4.59	5.74	1.53	0.77	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	11.49	9.68	7.86	3.33	0.60	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	15.47	11.94	8.40	1.99	0.00	0.44	0.44
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	4.07	11.52	5.42	3.39	1.36	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	71.53	40.88	30.66	0.00	10.22	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	4.88	11.58	6.10	3.05	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	5.04	6.92	7.55	2.52	0.94	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	4.24	7.57	7.57	2.72	1.21	0.61	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	4.75	5.54	9.49	1.58	0.00	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	27.21	7.94	4.53	1.13	1.13	1.13	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	40.46	15.17	5.06	0.00	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	14.04	11.18	4.47	2.11	0.37	1.12	0.50
Myoblast, donor2	11322-117D8	13.43	10.74	6.71	2.30	0.38	0.96	0.77
Myoblast, donor3	11398-118D3	24.05	17.99	8.91	1.68	1.51	0.84	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	32.11	21.60	11.09	2.63	1.75	1.17	0.44
Natural Killer Cells, donor1	11230-116C6	14.45	26.75	39.98	1.54	0.62	7.69	0.62
Natural Killer Cells, donor2	11311-117C6	13.87	28.04	41.31	0.00	0.60	7.84	1.81
Natural Killer Cells, donor3	11387-118C1	16.01	26.69	34.23	0.92	0.74	4.97	0.74
Neural stem cells, donor1	11275-116H6	26.13	25.04	11.61	2.90	0.73	0.73	0.36
Neural stem cells, donor2	11352-117H2	36.59	25.03	17.33	1.93	1.93	0.00	0.00
Neurons, donor1	11494-119E9	29.59	18.21	11.38	3.41	2.28	1.14	0.00
Neurons, donor2	11574-120E8	16.07	19.15	11.67	5.50	1.54	1.54	0.88
Neurons, donor3	11655-122E8	24.66	13.15	13.15	4.11	0.82	1.64	0.82
Neutrophils, donor1	11233-116C9	17.63	16.70	6.50	0.00	0.00	1.86	0.93
Neutrophils, donor2	11314-117C9	2.90	11.60	2.90	2.90	0.00	2.90	0.00
Neutrophils, donor3	11390-118C4	12.22	14.66	7.94	2.44	0.00	3.67	2.44
Nucleus Pulposus Cell, donor1	11252-116F1	11.99	9.86	7.72	1.42	0.95	0.12	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	6.51	4.88	3.26	0.65	0.33	0.65	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	6.22	7.22	3.61	1.60	0.40	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	7.30	8.26	5.09	0.69	0.28	0.00	0.00
Olfactory epithelial cells, donor2	11934-125I8	9.12	9.41	6.08	1.59	0.72	0.43	0.00
Olfactory epithelial cells, donor3	11935-125I9	8.74	8.74	7.49	0.91	0.57	0.11	0.23
Olfactory epithelial cells, donor4	11936-126A1	8.38	9.64	7.89	1.36	0.97	0.29	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	15.05	16.25	1.81	5.42	1.81	1.81	0.60
Osteoblast - differentiated, donor1	11276-116H7	4.04	6.81	5.53	1.49	0.21	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	0.00	3.43	2.29	0.00	0.00	1.14	0.00
Osteoblast - differentiated, donor3	11425-118G3	3.10	2.48	4.34	0.00	0.62	0.00	0.00
Osteoblast, donor1	11277-116H8	5.67	7.04	3.91	0.98	0.59	0.39	0.00
Osteoblast, donor2	11354-117H4	23.88	24.58	8.43	2.11	1.40	0.00	0.00
Osteoblast, donor3	11426-118G4	11.73	15.46	7.82	2.84	0.71	0.36	1.24
Pancreatic stromal cells, donor1	11249-116E7	18.11	16.43	7.08	1.85	1.26	0.59	0.17
Pericytes, donor1	11491-119E6	2.11	1.56	1.22	1.00	0.00	0.00	0.00
Pericytes, donor2	11571-120E5	2.72	2.94	2.49	0.45	0.00	0.23	0.23
Pericytes, donor3	11652-122E5	4.27	5.09	2.24	0.61	0.00	0.41	0.00
Perineurial Cells, donor1	11499-119F5	11.98	16.16	7.46	4.41	0.45	0.57	0.00
Perineurial Cells, donor2	11579-120F4	18.68	15.27	5.98	3.31	1.20	0.46	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	17.85	21.36	33.47	1.59	0.96	5.74	1.27
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	9.30	14.20	14.69	0.98	1.22	3.67	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	9.19	14.62	24.20	1.42	0.78	4.40	1.16
Placental Epithelial Cells, donor1	11278-116H9	8.13	4.78	3.35	0.96	0.48	1.20	0.48
Placental Epithelial Cells, donor2	11355-117H5	6.65	4.44	0.00	3.33	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	6.68	3.14	3.93	0.98	0.20	0.39	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	2.85	2.85	1.27	0.63	0.63	0.00	0.32
Preadipocyte - breast, donor1	11467-119B9	9.75	8.07	6.19	0.94	0.38	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	11.49	11.88	10.31	4.83	0.39	0.91	0.26
Preadipocyte - breast, donor2	11328-117E5	7.43	7.66	4.05	0.90	0.00	0.00	0.23
Preadipocyte - omental, donor1	11468-119C1	9.48	8.74	6.18	0.85	0.32	0.43	0.11
Preadipocyte - omental, donor2	11329-117E6	11.35	10.04	5.67	2.62	0.87	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	9.02	8.02	5.59	1.29	0.29	0.29	0.29
Preadipocyte - perirenal, donor1	11469-119C2	3.94	3.94	5.91	3.94	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	11.06	9.52	4.30	0.31	0.61	0.92	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	24.97	25.14	8.50	2.83	0.53	0.53	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	14.47	13.45	5.79	1.02	0.68	0.17	0.68
Preadipocyte - visceral, donor1	11280-116I2	23.85	23.47	7.92	2.33	1.21	0.28	0.09
Preadipocyte - visceral, donor2	11357-117H7	20.71	20.71	5.52	1.38	1.38	0.46	0.92
Preadipocyte - visceral, donor3	11429-118G7	16.41	15.26	5.12	2.19	0.21	0.31	0.73
Prostate Epithelial Cells (polarized), donor1	11253-116F2	47.67	21.87	4.68	6.18	2.26	1.06	0.75
Prostate Epithelial Cells, donor2	11331-117E8	11.10	7.04	3.11	2.17	0.27	0.95	0.14
Prostate Epithelial Cells, donor3	11404-118D9	6.98	4.41	1.59	1.29	0.43	0.86	0.18
Prostate Stromal Cells, donor1	11254-116F3	17.65	14.69	6.04	2.62	0.46	1.25	0.46
Prostate Stromal Cells, donor2	11332-117E9	16.67	12.01	3.59	3.05	0.90	0.54	0.36
Prostate Stromal Cells, donor3	11405-118E1	7.92	7.20	4.90	1.04	0.63	0.52	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	4.74	4.01	1.46	0.36	0.00	0.73	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	11.23	10.88	3.60	3.40	0.76	0.62	0.28
Renal Epithelial Cells, donor1	11517-119H5	3.55	3.04	0.51	1.01	0.00	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	5.69	3.56	3.56	0.00	0.71	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	15.46	15.35	5.50	2.54	0.32	0.32	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	2.72	4.09	4.09	1.36	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	8.36	5.39	2.29	2.02	0.13	0.27	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	20.87	17.98	5.33	3.77	0.89	1.11	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	3.33	1.33	1.33	0.67	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	5.50	4.40	1.98	0.88	0.00	0.00	0.00
Renal Mesangial Cells, donor2	11598-120H5	3.13	3.76	3.13	1.88	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	1.11	2.22	2.22	0.83	0.00	0.28	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	12.88	9.13	2.42	2.95	0.54	0.81	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	5.48	2.53	2.11	0.42	0.84	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	4.24	4.05	3.86	1.74	0.39	0.19	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	11.15	9.59	3.11	2.59	1.30	0.26	1.04
Retinal Pigment Epithelial Cells, donor1	11528-119I7	6.82	7.11	3.13	1.99	0.00	0.57	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	7.20	7.20	1.03	0.00	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	8.78	7.53	3.51	3.51	1.00	0.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	19.64	12.16	6.95	3.07	0.80	0.94	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	43.78	21.44	7.15	2.68	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	64.94	18.16	7.71	3.30	1.10	0.55	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	56.85	33.06	7.54	4.06	2.90	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	67.09	40.44	8.32	8.84	1.95	1.56	0.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	34.96	26.91	8.44	5.46	1.09	1.99	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	50.86	38.93	10.04	7.36	2.01	1.45	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	63.26	39.45	8.43	7.94	1.98	2.23	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	40.21	26.46	7.11	6.76	1.75	1.75	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	45.53	36.06	11.79	8.09	1.62	1.62	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	50.93	31.08	9.04	7.53	1.37	0.41	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	39.63	25.57	7.11	5.60	1.21	1.06	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	47.66	31.54	11.65	8.24	1.79	1.43	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	52.51	32.42	10.62	8.32	2.01	1.43	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	33.48	24.68	7.94	6.33	0.97	1.29	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	38.72	29.21	10.40	4.65	1.11	0.89	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	60.41	32.50	8.79	10.51	1.72	0.57	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	38.85	26.55	8.76	4.66	0.93	1.49	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	78.92	53.37	12.21	5.83	2.07	2.07	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	53.35	28.27	8.49	7.70	1.06	1.33	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	38.74	26.96	7.69	5.84	1.65	2.73	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	45.83	37.24	9.36	3.63	1.15	1.15	0.95
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	49.12	30.44	8.54	8.86	2.03	1.17	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	40.64	22.70	7.29	4.48	0.84	1.12	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	41.19	35.21	9.06	4.44	1.88	1.03	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	52.88	31.36	8.20	5.65	1.64	0.73	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	26.98	21.09	6.38	4.41	1.23	1.84	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	42.98	27.94	8.60	6.18	1.34	1.88	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	75.48	37.50	7.78	6.84	1.42	0.71	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	38.29	22.82	7.74	2.78	2.38	0.60	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	43.96	29.23	8.42	4.21	2.10	2.10	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	54.74	35.25	8.71	7.67	2.28	0.62	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	45.79	28.09	9.51	5.31	0.22	1.33	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	46.79	28.20	9.40	5.64	1.04	0.84	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	60.70	34.45	9.02	8.48	1.75	1.35	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	41.21	27.25	9.71	5.11	2.04	0.51	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	42.03	25.26	9.06	4.24	1.74	0.77	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	66.88	33.70	9.63	5.85	2.58	1.20	1.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	36.49	25.79	9.05	6.45	1.37	0.82	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	51.06	34.80	11.49	3.94	2.63	1.48	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	54.54	22.33	7.67	8.18	1.53	1.19	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	38.76	21.01	8.73	5.18	1.63	1.33	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	42.65	29.05	9.06	5.60	2.13	2.67	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	38.99	22.12	6.36	8.02	2.35	0.41	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	32.62	17.14	6.43	5.24	0.71	1.67	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	40.71	32.05	10.08	7.46	1.61	2.02	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	41.53	18.93	5.46	6.87	1.41	0.85	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	44.72	22.71	5.24	5.94	1.75	2.45	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	34.75	19.64	6.04	4.53	0.30	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	57.64	27.29	6.98	4.90	0.98	0.49	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	83.98	48.61	12.66	6.84	3.06	2.47	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	52.32	19.47	7.30	8.52	1.83	1.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	65.10	29.24	9.04	4.82	2.71	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	41.17	24.88	7.92	3.85	1.81	1.36	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	54.22	25.46	8.39	8.39	0.90	0.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	60.69	27.28	6.38	5.55	1.77	1.18	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	40.77	23.05	5.76	5.55	1.92	1.28	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	44.47	26.44	13.82	8.41	1.80	1.20	0.00
Schwann Cells, donor1	11498-119F4	4.70	5.27	2.82	1.69	0.19	0.75	0.19
Schwann Cells, donor2	11578-120F3	17.01	3.40	13.61	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	8.98	15.77	4.82	2.63	0.66	0.44	0.22
Sebocyte, donor1	11220-116B5	14.79	9.31	4.38	2.74	0.55	2.19	0.00
Sebocyte, donor2	11301-117B5	8.27	6.89	6.89	2.30	0.46	1.38	0.46
Sebocyte, donor3	11378-118B1	3.92	6.18	2.89	1.65	0.21	0.00	0.41
Sertoli Cells, donor1	11255-116F4	6.63	13.25	1.66	1.66	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	11.30	8.47	8.47	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	16.80	11.09	3.87	2.38	3.26	0.26	0.35
Skeletal Muscle Cells, donor2	11358-117H8	7.23	2.17	1.45	2.17	2.17	0.72	0.72
Skeletal Muscle Cells, donor3	11430-118G8	12.54	11.70	3.34	4.18	2.51	1.67	0.00
Skeletal Muscle Cells, donor4	11451-119A2	19.32	19.48	5.81	5.03	1.41	0.16	0.31
Skeletal Muscle Cells, donor5	11455-119A6	21.55	21.11	7.88	4.16	0.45	0.74	0.15
Skeletal Muscle Cells, donor6	11459-119B1	26.01	27.24	7.85	3.39	1.39	0.62	0.92
Skeletal Muscle Satellite Cells, donor1	11240-116D7	21.42	23.56	9.32	2.65	1.26	0.25	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	16.27	15.27	6.14	3.28	1.57	0.43	0.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	26.79	26.19	10.91	4.46	1.49	0.69	0.60
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	31.93	14.74	5.64	1.77	3.45	1.18	0.51
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	6.51	8.69	4.34	2.90	0.00	0.72	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	7.71	9.08	5.92	0.28	0.41	0.28	0.14
Skin - palm, donor1	10286-104F7	2.69	18.80	13.43	0.00	0.00	2.69	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	9.08	5.77	3.32	0.72	0.14	0.29	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	103.87	82.61	22.08	3.27	0.82	0.82	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	10.52	7.53	2.60	0.78	0.39	0.13	0.39
Small Airway Epithelial Cells, donor1	11256-116F5	12.93	7.78	3.48	1.25	0.42	0.56	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	12.38	5.63	3.94	1.41	0.28	0.84	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	59.42	53.07	19.45	8.03	1.90	3.17	1.06
Small Airway Epithelial Cells, donor3	11406-118E2	8.09	4.50	2.40	1.72	0.67	0.67	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	6.17	8.64	1.54	0.62	0.31	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	13.78	16.23	9.78	2.89	0.89	1.33	0.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	7.05	4.70	3.53	2.35	0.00	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	6.19	5.97	1.77	0.66	0.22	0.22	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	7.48	7.88	5.12	1.58	0.79	0.79	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	5.41	10.04	4.64	1.55	0.00	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	12.01	8.01	7.01	3.00	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	10.38	6.65	3.86	2.40	0.27	0.13	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	11.08	12.19	4.43	0.89	0.00	0.44	0.44
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	15.75	14.60	6.66	2.94	0.13	0.64	0.26
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	9.44	15.63	7.16	3.26	0.00	0.65	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	16.83	16.54	7.09	2.66	1.77	0.30	0.59
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	8.68	9.25	4.41	1.57	0.57	0.00	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	3.90	1.30	1.63	0.49	0.16	0.33	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	15.83	7.92	5.18	1.52	0.91	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	9.34	8.84	7.83	1.77	1.01	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	18.36	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	7.15	5.25	2.86	0.48	0.48	0.48	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	14.60	11.65	6.05	1.92	1.18	0.74	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	13.34	11.62	5.38	1.94	0.00	0.43	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	16.90	15.32	4.62	3.15	0.63	0.42	0.52
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	4.80	4.64	2.17	1.24	0.46	0.77	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	6.47	6.47	7.55	2.16	0.00	0.00	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	9.86	11.95	5.98	1.79	0.30	0.60	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	3.76	2.05	2.05	2.05	0.00	0.68	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	16.10	17.98	5.50	2.67	0.86	0.86	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	9.86	12.58	8.86	1.51	0.91	0.40	0.20
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	9.33	5.92	6.14	2.28	0.46	0.68	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	7.25	4.83	2.42	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	25.17	23.05	5.03	9.54	0.53	1.85	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	16.51	14.65	4.26	3.73	0.53	0.80	0.53
Smooth Muscle Cells - Prostate, donor2	11335-117F3	14.53	9.52	4.63	1.75	0.25	0.50	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	4.82	4.06	3.04	1.27	0.00	0.76	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	11.01	15.38	5.28	4.98	0.45	0.60	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	4.50	8.25	6.00	3.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	6.46	6.46	5.17	1.29	2.58	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	7.91	10.23	4.65	3.72	0.47	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	8.58	8.08	6.06	1.01	0.50	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	10.97	6.58	5.01	1.25	0.00	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	1.18	2.06	0.59	0.29	0.59	0.59	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	15.41	20.83	8.25	7.91	0.83	1.25	0.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	7.94	10.74	6.07	2.34	0.47	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	7.92	6.76	3.74	1.01	0.14	0.43	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	10.96	7.65	4.33	1.78	0.76	0.00	0.76
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	8.84	7.15	6.96	1.13	0.56	0.19	0.56
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	16.63	18.45	6.71	4.75	0.84	0.98	0.70
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	11.06	9.05	6.03	2.93	0.34	0.42	0.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	2.38	0.95	1.43	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	7.58	6.12	1.71	1.47	0.98	0.49	1.22
Smooth Muscle Cells - Uterine, donor1	11258-116F7	15.02	7.95	5.97	0.66	0.44	1.10	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	9.95	11.12	3.80	1.46	0.29	0.00	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	12.05	7.77	4.08	0.78	0.00	0.39	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	10.31	7.67	3.70	1.32	0.53	0.26	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	21.57	7.07	2.60	0.37	0.74	0.00	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	10.78	6.83	1.44	1.44	0.72	1.08	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	13.63	12.21	4.83	1.14	0.00	0.28	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	23.63	14.18	7.88	1.97	0.39	0.79	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	8.38	7.62	4.83	1.27	0.25	0.00	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	5.99	4.39	2.80	0.80	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	8.36	10.87	5.43	1.67	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	8.25	6.42	3.67	3.21	0.46	0.46	0.00
Synoviocyte, donor1	11291-117A4	9.26	7.41	4.04	0.84	0.67	0.17	0.17
Synoviocyte, donor2	11368-117I9	4.19	4.53	3.35	1.01	1.01	0.00	0.34
Synoviocyte, donor3	11440-118H9	5.36	5.14	5.36	1.34	0.22	0.22	0.00
Trabecular Meshwork Cells, donor1	11532-120A2	10.72	10.36	2.86	4.29	0.71	1.43	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	0.00	5.95	1.98	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	4.86	5.79	3.70	1.16	0.23	0.46	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	8.17	8.96	3.08	1.43	0.43	0.29	0.14
Tracheal Epithelial Cells, donor2	11369-118A1	4.25	6.57	1.93	2.32	0.39	0.77	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	9.16	3.44	2.86	5.15	1.15	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	19.81	13.90	6.89	4.18	0.74	1.35	0.25
Urethra, donor2	10319-105A4	14.39	16.19	21.58	5.40	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	2.66	1.06	2.39	0.80	0.27	0.27	0.00
Urothelial Cells, donor2	11600-120H7	2.40	2.40	0.00	0.80	0.00	0.80	0.00
Urothelial Cells, donor3	11681-122H7	2.98	2.75	1.60	1.15	0.00	0.00	0.00
Urothelial cells, donor0	11216-116B1	6.46	7.58	2.23	2.67	0.45	0.00	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	9.79	15.13	8.90	3.56	0.89	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	11.44	10.01	17.16	1.43	0.00	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	5.48	12.32	10.27	2.05	0.00	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	8.26	11.71	22.04	2.07	0.34	0.69	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	6.39	12.78	19.17	2.32	0.00	0.58	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	11.45	10.41	16.66	0.00	0.00	3.12	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	14.68	15.60	17.44	2.75	0.92	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	10.04	5.48	15.52	2.74	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	15.54	27.02	16.28	8.02	1.36	0.62	0.25
Wilms' tumor cell line:HFWT	10597-108E3	0.88	11.44	13.20	3.52	0.00	0.00	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	5.87	6.98	1.96	6.70	0.84	1.68	0.56
achilles tendon, donor2	10292-104G4	2.07	16.53	18.60	2.07	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	22.69	26.01	17.08	10.20	3.82	0.51	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	26.70	35.99	22.99	7.89	2.79	2.32	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	22.55	32.76	26.23	5.70	0.83	1.42	0.47
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	9.80	30.48	32.38	9.80	0.54	2.72	2.18
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	20.52	30.92	11.81	7.59	0.28	1.12	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	23.90	28.34	13.53	5.29	1.06	0.42	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	14.70	10.89	5.99	2.18	0.82	0.27	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	35.25	26.00	15.86	4.41	1.32	0.88	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	17.15	17.97	15.52	7.35	1.23	0.41	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	27.57	34.95	29.90	1.55	0.00	0.39	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	59.06	43.42	12.14	4.97	3.50	0.92	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	39.01	42.91	46.81	7.80	0.00	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	18.36	31.37	18.59	4.18	1.16	0.23	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	17.61	23.04	9.84	3.11	1.81	0.78	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	16.95	18.41	10.52	1.75	0.58	0.29	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	32.53	20.91	7.90	2.79	0.46	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	43.59	31.67	5.76	2.88	1.65	0.82	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	23.33	19.95	10.74	5.22	1.53	1.53	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	51.21	35.84	10.24	6.40	1.71	2.56	1.71
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	44.28	31.85	13.34	4.55	3.34	3.64	0.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	54.88	38.99	12.04	2.89	1.44	2.17	1.93
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	41.21	36.75	9.13	3.56	2.23	1.34	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	27.02	21.35	9.67	3.67	0.33	1.33	1.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	9.29	13.01	16.72	1.86	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	27.87	33.15	17.33	4.90	0.00	1.13	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	41.87	38.38	13.52	3.93	1.74	0.44	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	15.00	5.62	3.75	1.87	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	32.50	16.96	6.12	2.12	3.06	1.88	0.24
adipose tissue, adult, pool1	10010-101C1	12.41	8.69	8.38	3.88	0.78	0.47	0.00
adipose, donor1	10184-103D4	12.31	17.01	4.10	24.04	4.69	2.35	0.59
adipose, donor2	10185-103D5	4.06	6.49	3.65	11.35	1.22	0.41	0.00
adipose, donor3	10186-103D6	10.35	8.44	3.54	11.16	0.54	1.91	0.54
adipose, donor4	10187-103D7	18.20	7.80	7.80	9.53	1.73	3.47	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	7.10	17.99	14.84	7.73	0.47	1.58	0.16
adrenal gland, adult, pool1	10081-102A9	3.64	14.55	3.64	7.28	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	16.54	12.01	5.34	3.60	1.07	0.27	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	21.80	38.23	21.44	4.64	1.43	0.71	0.36
amniotic membrane cells, donor1	12235-129G3	8.11	4.17	2.09	2.32	0.70	0.23	0.46
amniotic membrane cells, donor2	12236-129G4	10.82	6.76	6.42	4.40	0.68	0.34	1.69
amniotic membrane cells, donor3	12237-129G5	7.07	7.07	4.71	2.36	0.00	0.29	0.29
amygdala - adult, donor10196	10167-103B5	24.90	21.34	15.42	2.37	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	19.67	17.03	12.77	2.64	0.61	0.61	0.20
amygdala, newborn, donor10223	10360-105E9	25.50	20.33	10.97	1.61	0.32	0.65	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	21.77	16.81	8.91	2.16	1.27	0.38	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	22.50	22.50	10.15	10.15	1.99	2.21	1.10
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	73.15	27.39	15.70	6.68	4.01	1.67	0.00
aorta, adult, pool1	10052-101G7	4.31	7.65	10.40	2.94	0.20	0.39	0.20
appendix, adult	10189-103D9	15.91	23.68	27.17	2.72	1.16	0.00	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	85.30	29.92	5.50	4.47	6.19	1.03	0.00
artery, adult	10190-103E1	14.95	13.59	2.72	1.36	4.08	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	35.35	18.25	7.10	6.08	0.29	0.87	0.14
b cell line:RPMI1788	10427-106D4	16.65	16.80	7.88	3.72	1.93	0.30	0.59
basal cell carcinoma cell line:TE 354.T	10702-109G9	11.65	9.71	7.49	1.66	0.55	0.83	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	31.06	16.67	6.35	3.47	1.98	0.60	0.40
bile duct carcinoma cell line:TFK-1	10496-107C1	13.89	6.70	1.51	2.01	1.34	0.67	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	30.20	12.86	9.51	2.80	5.59	0.56	0.00
bladder, adult, pool1	10011-101C2	5.11	5.11	7.06	3.59	0.43	0.54	0.43
blood, adult, pool1	10053-101G8	6.64	15.50	13.29	2.21	2.21	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	11.13	5.14	5.99	6.85	2.57	0.00	0.00
bone marrow, adult	10192-103E3	26.99	12.15	6.07	1.35	0.67	1.35	0.67
brain, adult, donor1	10084-102B3	19.48	13.33	10.25	3.08	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	13.14	11.80	10.69	2.12	0.45	0.33	0.11
brain, fetal, pool1	10085-102B4	24.04	13.36	18.70	5.34	2.67	2.67	2.67
breast carcinoma cell line:MCF7	10482-107A5	14.87	11.23	7.27	4.96	1.32	2.31	1.65
breast carcinoma cell line:MDA-MB-453	10419-106C5	17.60	10.86	6.12	2.87	0.87	0.00	0.00
breast, adult, donor1	10080-102A8	9.47	9.47	8.84	5.68	1.89	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	8.13	14.23	5.84	5.59	0.89	0.51	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	23.50	21.95	4.64	3.40	2.78	1.55	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	24.63	23.02	12.43	2.53	0.92	0.23	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	23.48	13.31	6.05	3.15	3.39	0.73	0.00
carcinoid cell line:NCI-H1770	10703-109H1	44.67	26.33	6.58	15.99	4.23	0.94	0.94
carcinoid cell line:NCI-H727	10735-110B6	30.08	17.61	5.03	5.80	0.88	0.55	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	19.01	26.62	11.41	3.80	1.90	0.95	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	49.51	35.40	9.05	6.92	3.19	0.53	0.27
caudate nucleus - adult, donor10196	10177-103C6	14.97	26.48	23.03	2.30	1.15	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	13.39	19.08	19.08	4.18	0.17	1.00	1.17
caudate nucleus, adult, donor10258	10379-105H1	10.70	26.74	36.68	4.58	0.00	0.00	0.76
caudate nucleus, newborn, donor10223	10354-105E3	21.97	19.41	20.88	4.03	1.10	1.83	1.10
cerebellum - adult, donor10196	10173-103C2	37.87	14.57	34.96	17.48	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	26.48	20.92	13.88	8.11	2.35	0.64	0.21
cerebellum, adult, pool1	10083-102B2	8.28	11.73	11.04	5.86	0.69	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	65.59	30.72	19.10	7.47	6.64	4.98	0.83
cerebral meninges, adult	10188-103D8	15.13	13.36	13.11	2.27	1.01	0.00	0.25
cerebrospinal fluid, donor2	10294-104G6	4.39	5.85	8.04	1.46	0.73	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	34.22	17.25	3.16	2.59	7.33	4.03	0.58
cervical cancer cell line:ME-180	10553-107I4	92.97	33.64	10.94	5.97	3.65	1.66	1.33
cervix, adult, pool1	10013-101C4	8.19	9.13	9.03	4.93	0.52	0.21	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	10.45	10.87	6.69	5.71	0.14	1.11	0.56
chondrosarcoma cell line:SW 1353	10700-109G7	6.53	3.92	10.45	3.92	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	36.79	14.79	4.23	7.08	3.73	0.87	1.12
choriocarcinoma cell line:SCH	10785-110H2	14.91	7.15	3.82	7.89	0.74	0.49	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	23.72	11.15	3.32	6.40	1.42	0.95	0.00
chorionic membrane cells, donor1	12238-129G6	6.27	3.42	3.70	0.28	0.28	0.85	0.00
chorionic membrane cells, donor2	12239-129G7	14.82	12.13	6.16	3.48	0.89	0.50	0.30
chorionic membrane cells, donor3	12240-129G8	6.59	11.54	3.85	2.75	1.10	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	13.13	16.16	11.11	2.02	0.00	2.02	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	24.78	31.12	13.45	5.38	0.96	1.15	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	18.16	23.02	15.42	3.59	1.48	0.21	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	44.68	27.48	10.79	7.96	2.05	1.80	1.03
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	49.59	39.18	9.43	7.98	1.45	0.97	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	53.14	38.69	10.59	7.53	1.63	2.24	0.61
chronic myelogenous leukemia cell line:K562	10454-106G4	63.01	62.13	11.78	12.66	2.94	1.77	0.88
chronic myelogenous leukemia cell line:KU812	10409-106B4	25.02	32.32	11.47	9.64	0.00	1.30	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	7.77	8.69	4.11	2.51	0.00	0.46	0.23
clear cell carcinoma cell line:TEN	10636-108I6	10.93	6.59	2.26	2.60	0.35	0.35	0.52
colon carcinoma cell line:CACO-2	10513-107D9	60.04	31.48	7.87	5.86	3.11	0.73	0.18
colon carcinoma cell line:COLO-320	10420-106C6	79.44	47.51	9.12	11.02	7.22	1.52	0.76
colon, adult, donor1	10082-102B1	27.37	13.09	11.90	4.76	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	14.57	11.05	6.11	3.17	1.53	0.24	0.00
colon, fetal, donor1	10070-101I7	19.78	19.16	12.36	5.56	1.24	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	22.92	41.25	55.00	27.50	0.00	9.17	4.58
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	50.07	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	63.31	45.89	10.62	2.12	4.67	1.70	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	40.90	34.56	11.77	1.21	1.66	0.75	0.91
cord blood derived cell line:COBL-a untreated	10449-106F8	53.44	39.77	12.13	2.12	3.24	1.55	0.42
corpus callosum, adult, pool1	10042-101F6	14.37	16.14	14.15	6.52	1.11	0.33	0.11
cruciate ligament, donor2	10295-104G7	8.10	13.78	11.35	2.43	0.00	1.62	0.00
diaphragm, fetal, donor1	10069-101I6	4.82	8.83	9.63	3.21	0.80	0.00	2.41
diencephalon, adult	10193-103E4	8.64	12.24	13.44	3.12	0.00	0.48	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	38.35	28.01	11.02	2.53	2.53	1.38	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	45.13	21.54	5.64	3.85	1.80	1.28	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	20.94	16.61	6.50	4.33	0.96	1.20	0.48
ductus deferens, adult	10196-103E7	16.94	12.96	12.96	1.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	10.08	5.76	18.72	10.08	2.88	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	16.18	15.45	10.30	7.36	0.00	0.74	0.74
dura mater, adult, donor1	10041-101F5	9.25	8.84	11.64	3.47	0.33	0.99	0.50
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	49.52	11.10	4.44	0.44	1.78	0.22	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	24.50	14.47	5.45	1.58	1.58	1.29	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	8.63	13.57	8.63	3.08	1.85	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	10.59	13.92	5.15	2.72	0.61	0.61	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	17.29	13.89	8.34	3.40	0.93	1.85	0.31
embryonic pancreas cell line:2C6	10603-108E9	18.39	15.76	13.13	6.57	1.31	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	9.39	7.71	3.02	8.72	1.01	2.01	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	12.14	13.23	7.43	2.54	1.81	0.54	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	14.31	11.74	4.66	3.06	0.16	0.80	0.48
epidermoid carcinoma cell line:A431	10426-106D3	20.23	12.78	4.56	2.56	0.78	0.33	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	51.80	27.06	8.03	5.83	3.41	1.21	0.44
epididymis, adult	10197-103E8	6.91	9.84	9.21	3.77	1.05	0.42	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	3.90	9.23	8.52	6.56	0.18	0.18	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	8.65	14.16	7.47	1.57	0.00	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	55.30	23.98	6.03	4.19	4.72	1.57	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	51.08	23.52	6.00	4.23	5.12	0.89	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	56.91	29.58	6.61	5.71	4.37	1.46	0.78
esophagus, adult, pool1	10015-101C6	7.96	6.80	6.16	3.40	1.06	0.64	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	11.15	21.29	13.90	7.39	0.88	2.63	1.00
eye - muscle inferior rectus, donor1	10272-104E2	26.56	26.56	21.73	2.41	2.41	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	25.25	10.52	8.42	4.21	2.10	2.10	0.00
eye - muscle medial, donor2	10299-104H2	16.37	13.39	10.42	7.44	1.49	2.98	0.00
eye - muscle superior, donor2	10297-104G9	17.20	16.05	12.61	1.15	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	18.95	26.23	18.95	2.91	0.00	1.46	2.91
eye, fetal, donor1	10054-101G9	7.12	7.63	11.19	3.05	0.25	0.00	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	23.34	25.00	11.67	4.23	1.03	0.13	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	14.25	13.77	12.11	6.41	0.95	0.24	0.24
frontal lobe, adult, pool1	10040-101F4	22.42	18.30	14.36	2.81	0.84	0.00	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	45.94	32.73	13.51	12.31	2.10	2.40	0.90
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	5.03	9.78	6.40	4.94	0.18	0.73	0.18
gall bladder, adult	10198-103E9	10.38	9.42	6.76	1.93	0.72	0.72	0.24
gamma delta positive T cells, donor1	11937-126A2	9.66	31.14	47.78	2.15	0.00	1.61	0.54
gamma delta positive T cells, donor2	11938-126A3	12.70	23.90	35.86	1.12	0.00	0.37	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	28.73	19.43	9.29	5.28	2.11	1.27	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	18.76	9.48	5.22	3.87	1.35	0.19	0.39
gastric cancer cell line:AZ521	10549-107H9	30.17	26.89	11.64	4.26	1.48	0.66	0.33
gastric cancer cell line:GSS	10560-108A2	7.32	9.15	15.56	1.83	0.92	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	38.61	16.45	3.20	5.03	1.60	1.37	0.23
giant cell carcinoma cell line:LU65	10487-107B1	11.59	9.06	2.18	4.59	1.15	1.38	0.57
giant cell carcinoma cell line:Lu99B	10433-106E1	22.25	15.82	11.06	3.50	0.70	1.26	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	28.68	21.70	8.73	5.74	1.50	1.50	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	31.24	22.90	12.14	3.06	2.96	0.53	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	22.61	22.75	14.04	3.23	2.67	0.56	0.00
glioblastoma cell line:T98G	10485-107A8	15.89	14.46	7.17	3.53	1.21	0.33	0.22
glioma cell line:GI-1	10413-106B8	11.13	7.91	4.98	3.51	1.17	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	7.29	19.68	18.22	2.19	1.46	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	17.33	20.50	14.40	4.64	0.49	0.49	0.73
globus pallidus, adult, donor10258	10367-105F7	10.95	10.95	15.06	1.37	1.37	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	16.52	12.26	10.13	1.60	0.00	1.07	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	102.78	53.84	97.89	19.58	2.45	7.34	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	43.71	10.93	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	15.68	5.23	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	11.20	15.36	5.76	3.20	0.96	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	16.53	18.82	5.51	21.12	1.38	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	23.78	17.83	4.57	16.00	2.29	1.83	0.46
hIPS +CCl2, biol_rep3	14385-156C2	23.19	18.68	5.15	22.54	0.64	0.64	1.29
hIPS, biol_rep1	14380-156B6	27.31	25.87	12.94	18.68	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	12.35	20.58	4.80	14.40	0.00	0.69	0.00
hIPS, biol_rep3	14382-156B8	15.45	23.17	22.07	2.21	2.21	0.00	2.21
hairy cell leukemia cell line:Mo	10712-109I1	22.41	22.13	10.92	2.30	1.44	0.29	0.29
heart - mitral valve, adult	10205-103F7	11.96	9.27	12.26	3.29	0.90	1.79	0.60
heart - pulmonic valve, adult	10206-103F8	7.84	4.45	3.66	4.45	0.26	0.52	0.00
heart - tricuspid valve, adult	10207-103F9	9.99	20.82	13.32	5.00	0.00	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	7.35	9.18	7.14	2.24	0.61	0.82	0.20
heart, adult, diseased, donor1	10051-101G6	8.09	9.37	7.66	3.83	0.43	0.85	0.00
heart, adult, pool1	10016-101C7	7.82	7.13	4.37	6.44	0.69	0.46	0.23
heart, fetal, pool1	10046-101G1	22.28	15.81	10.06	10.27	1.54	1.64	0.41
hepatic mesenchymal tumor cell line:LI90	10778-110G4	8.33	7.40	7.10	2.16	0.62	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	26.16	9.51	2.38	2.38	1.19	1.19	2.38
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	50.17	26.85	5.41	4.42	2.32	0.55	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	47.58	25.85	5.83	4.13	2.18	0.36	0.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	54.97	29.91	6.27	6.57	2.73	0.91	0.20
hepatoma cell line:Li-7	10484-107A7	26.58	10.01	3.11	9.12	2.34	1.89	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	43.42	26.93	8.44	7.44	4.12	1.01	0.00
hippocampus - adult, donor10196	10169-103B7	32.18	17.03	18.93	0.95	0.95	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	25.92	17.96	12.86	3.27	0.82	0.61	0.61
hippocampus, adult, donor10258	10374-105G5	34.86	21.41	16.93	2.49	1.49	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	23.26	15.16	10.93	1.41	2.11	0.70	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	23.19	16.48	8.54	15.26	1.83	9.16	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	9.82	11.58	2.16	10.80	1.57	5.30	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	12.69	8.38	4.06	10.66	1.27	4.57	1.78
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	10.15	11.84	1.69	11.28	1.13	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	6.71	8.00	3.87	11.10	1.55	1.29	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	7.21	14.80	4.93	5.31	1.14	1.90	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	26.86	13.72	4.67	7.59	1.17	2.34	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	18.10	11.42	3.45	11.20	1.29	1.29	0.65
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	22.10	12.10	7.51	7.51	2.50	2.09	0.83
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	15.39	17.05	6.39	9.95	1.89	1.89	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	18.32	12.05	3.86	7.55	1.29	1.61	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	16.83	17.51	4.04	5.39	0.67	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	3.91	4.38	0.94	14.24	0.94	3.29	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	6.39	5.90	1.47	19.16	0.49	2.46	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	7.85	6.11	3.49	13.96	0.87	2.62	3.49
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	4.58	5.54	2.48	19.09	0.95	1.34	0.95
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	4.80	6.11	2.62	20.93	0.00	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	8.50	9.50	3.00	13.49	3.50	1.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	4.90	4.71	1.32	8.10	0.75	0.75	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	3.64	8.18	4.55	10.46	0.91	0.45	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	5.33	4.70	2.51	6.58	1.25	0.63	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	5.72	7.35	4.08	10.12	1.47	0.82	0.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	4.06	7.26	1.16	10.74	0.29	0.29	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	7.47	8.37	2.99	7.77	0.60	0.90	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	13.86	11.08	4.43	9.61	1.29	2.77	0.92
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	13.41	8.84	3.71	16.26	1.71	5.14	1.14
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	25.72	16.74	5.72	16.33	4.08	7.35	2.45
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	15.49	14.44	5.28	8.45	1.06	0.00	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	12.04	10.14	5.07	11.72	0.32	0.63	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	15.43	12.41	5.45	6.36	0.30	1.51	1.21
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	18.62	11.38	5.69	8.79	1.55	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	27.23	15.94	7.31	4.65	0.00	0.66	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	31.04	14.88	5.39	2.82	1.80	1.03	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	24.29	14.57	7.16	3.83	1.79	0.77	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	35.59	18.17	12.12	6.06	1.51	1.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	22.18	20.16	4.70	2.02	2.02	1.68	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	13.28	10.63	3.14	14.25	1.69	3.38	1.21
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	23.62	12.48	5.79	5.79	1.78	3.12	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	13.17	13.17	3.41	8.78	1.46	1.95	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	21.70	15.59	3.97	7.03	2.75	0.92	0.92
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	100.85	39.04	22.77	22.77	3.25	3.25	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	23.83	19.86	6.29	5.30	2.65	1.65	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	26.82	16.97	8.21	6.02	1.64	1.09	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	20.27	9.41	7.24	4.70	0.36	0.72	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	22.42	16.37	5.69	4.98	0.71	1.42	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	21.48	15.51	4.77	5.97	1.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	30.20	21.80	7.45	5.96	2.17	2.44	0.81
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	22.90	15.62	2.16	5.39	2.16	1.08	0.81
immature langerhans cells, donor1	11904-125F5	26.39	9.44	5.81	1.70	1.21	1.45	0.73
immature langerhans cells, donor2	11905-125F6	10.30	9.51	3.17	3.17	0.00	5.54	1.58
insula, adult, pool1	10039-101F3	27.54	22.24	17.89	2.08	1.14	0.38	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	14.31	15.28	8.78	3.90	1.30	0.65	0.65
kidney, adult, pool1	10017-101C8	10.21	14.12	8.01	3.70	0.50	0.30	0.60
kidney, fetal, pool1	10045-101F9	14.08	13.02	9.05	3.82	0.85	1.06	0.57
large cell lung carcinoma cell line:IA-LM	10509-107D5	16.90	12.07	5.25	4.69	0.85	1.42	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	14.52	8.29	3.04	1.94	2.90	0.83	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	25.51	10.83	3.30	3.30	1.83	0.92	0.00
left atrium, adult, donor1	10079-102A7	5.45	4.36	5.99	2.18	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	5.06	4.55	5.06	2.02	1.01	1.01	0.00
leiomyoblastoma cell line:G-402	10721-110A1	5.20	25.17	18.06	13.13	0.00	0.82	0.00
leiomyoma cell line:10964C	10569-108B2	5.39	3.95	2.16	0.72	0.36	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	7.61	6.52	3.26	0.54	0.00	0.54	0.54
leiomyoma cell line:15425	10571-108B4	7.77	6.80	5.58	0.97	0.73	0.24	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	0.00	0.00	0.00	0.00	6.35	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	21.96	14.64	9.41	2.09	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	24.79	17.24	4.72	3.19	0.71	0.47	0.24
liposarcoma cell line:KMLS-1	10782-110G8	17.65	12.97	7.19	1.09	1.41	0.16	0.31
liposarcoma cell line:SW 872	10726-110A6	27.54	22.91	10.60	3.78	1.22	0.73	0.12
liver, adult, pool1	10018-101C9	16.37	8.43	4.05	2.27	0.97	0.49	0.16
liver, fetal, pool1	10086-102B5	8.47	4.70	6.58	0.00	0.00	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	12.83	13.27	13.27	2.92	0.58	0.58	0.15
locus coeruleus, adult, donor10252	10165-103B3	11.81	13.84	8.67	4.24	1.11	1.11	0.37
locus coeruleus, adult, donor10258	10375-105G6	10.16	9.59	11.29	4.23	0.00	0.00	0.28
locus coeruleus, newborn, donor10223	10362-105F2	29.02	16.40	7.15	1.68	2.10	0.84	0.00
lung adenocarcinoma cell line:A549	10499-107C4	9.27	7.20	3.60	1.80	1.66	0.42	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	16.55	8.27	5.52	4.14	2.76	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	5.27	6.99	4.35	3.56	0.26	0.66	0.13
lung, adult, pool1	10019-101D1	6.85	7.80	6.62	3.07	1.06	1.18	0.12
lung, fetal, donor1	10068-101I5	27.40	24.26	13.41	7.14	1.14	1.71	0.00
lung, right lower lobe, adult, donor1	10075-102A3	6.87	10.08	13.29	2.29	0.92	0.46	0.00
lymph node, adult, donor1	10077-102A5	6.63	7.10	16.57	1.89	0.47	0.47	0.00
lymphangiectasia cell line:DS-1	10727-110A7	15.34	7.45	4.16	4.82	1.53	1.10	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	55.09	51.16	17.05	3.62	4.23	0.60	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	35.68	10.19	5.95	5.95	0.00	0.00	0.85
mature adipocyte, donor1	12231-129F8	11.10	7.99	4.44	3.55	0.00	0.44	0.00
mature adipocyte, donor2	12232-129F9	13.28	5.60	3.53	1.25	0.62	0.42	0.21
mature adipocyte, donor3	12233-129G1	9.01	4.27	3.08	1.19	0.47	0.71	0.24
mature adipocyte, donor4	12234-129G2	11.84	5.79	5.00	2.11	0.79	0.00	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	34.55	25.02	7.86	7.15	1.67	0.95	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	25.94	20.30	15.79	4.51	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	22.80	22.80	9.38	3.49	1.10	0.37	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	20.65	15.88	15.88	1.91	0.95	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	49.47	32.41	14.93	2.13	2.13	0.85	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	19.58	20.08	19.07	1.86	1.86	0.17	0.17
medial temporal gyrus, adult, donor10252	10156-103A3	21.01	18.46	10.40	3.82	0.85	0.64	0.21
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	44.30	28.89	17.34	1.93	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	43.06	28.71	43.06	14.35	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	27.28	21.54	8.97	1.44	1.08	1.08	0.00
medulla oblongata - adult, donor10196	10174-103C3	14.28	13.63	12.33	3.24	0.00	0.65	0.65
medulla oblongata, adult, donor10252	10155-103A2	15.94	11.92	6.35	3.10	0.46	0.62	0.31
medulla oblongata, adult, pool1	10038-101F2	16.08	15.10	11.02	3.75	0.41	0.90	0.00
medulla oblongata, newborn, donor10223	10361-105F1	21.53	19.09	12.50	1.74	0.69	1.39	0.35
medulloblastoma cell line:D283 Med	10838-111E1	21.48	29.89	16.38	8.19	2.44	0.44	0.22
medulloblastoma cell line:ONS-76	10759-110E3	19.56	23.84	12.11	8.19	0.86	0.49	0.61
melanoma cell line:COLO 679	10514-107E1	29.76	20.12	5.17	2.16	0.72	0.29	0.14
melanoma cell line:G-361	10465-106H6	24.70	18.73	11.13	4.61	0.81	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	8.32	7.78	0.72	0.90	0.54	0.00	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	121.60	68.73	18.50	4.41	10.57	2.64	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	76.99	68.69	29.55	6.74	1.30	2.85	1.04
mesenchymal precursor cell - adipose, donor1	11747-123G1	15.96	17.18	6.75	0.92	0.46	0.77	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	12.91	10.36	3.82	1.82	1.64	0.18	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	17.39	15.32	4.56	0.41	1.66	1.24	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	9.55	8.57	2.25	1.12	0.98	0.00	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	8.67	6.93	3.08	0.77	0.19	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	11.11	4.16	2.78	1.39	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	4.12	2.23	1.54	2.23	0.17	0.69	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	13.11	8.40	3.91	0.92	0.81	0.58	0.46
mesenchymal precursor cell - cardiac, donor3	11754-123G8	14.72	11.27	5.31	1.99	0.80	0.53	0.66
mesenchymal precursor cell - cardiac, donor4	11755-123G9	15.93	11.48	4.59	2.16	0.68	0.68	0.81
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	17.21	13.80	5.41	1.99	0.57	0.71	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	6.26	4.94	1.98	1.65	0.99	0.66	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	16.19	14.11	6.23	2.21	0.83	0.14	0.42
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	18.50	14.31	4.54	1.75	0.70	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	7.96	6.94	3.88	1.22	0.41	0.00	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	7.19	7.19	4.31	1.08	0.00	1.08	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	5.90	5.07	2.69	1.14	0.21	0.21	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	7.07	5.24	2.74	0.91	0.46	0.46	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	25.17	26.85	8.39	4.20	1.26	0.42	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	14.94	10.01	3.74	1.20	0.75	0.45	0.30
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	11.64	9.19	3.68	1.75	0.96	0.61	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	13.99	8.47	2.58	1.10	0.37	0.37	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	10.30	7.15	3.43	2.00	0.00	0.57	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	54.73	26.94	5.89	2.53	1.68	1.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	7.76	10.05	5.48	1.83	0.00	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	9.98	6.91	4.86	1.53	0.51	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	13.61	10.73	7.85	1.31	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	10.78	9.24	4.31	0.92	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	9.88	7.53	4.71	1.18	1.18	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	8.12	11.17	5.08	2.03	1.02	0.00	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	7.47	10.22	5.11	1.18	0.39	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	10.19	9.73	7.88	0.46	0.00	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	48.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	13.84	10.38	8.36	1.73	0.29	0.29	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	10.04	12.27	7.36	0.89	1.12	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	9.85	10.09	5.53	1.20	0.48	0.72	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	11.00	11.00	11.73	2.20	0.00	0.00	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	5.03	9.06	8.06	1.01	0.34	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	11.46	11.05	4.50	0.82	0.82	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	9.88	8.16	3.01	1.72	0.86	0.43	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	8.20	5.47	8.20	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	10.33	10.33	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	10.07	12.34	5.52	0.32	0.32	0.65	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	8.73	11.64	1.45	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	13.86	13.33	10.66	1.60	0.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	9.81	13.90	6.54	1.64	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	10.50	11.27	5.44	1.94	0.78	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	4.20	4.20	0.00	2.10	0.00	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	14.90	9.93	13.91	0.99	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	14.30	4.77	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	10.08	13.64	6.52	1.19	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	13.40	8.53	12.18	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	12.03	7.60	7.60	0.63	0.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	17.25	14.14	6.55	1.03	1.03	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	17.19	8.60	4.30	0.00	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	7.98	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	20.66	6.89	6.89	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	13.04	6.11	3.67	0.00	1.63	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	11.12	7.15	3.18	0.00	2.38	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	7.07	6.48	3.54	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	15.27	7.79	3.43	0.31	0.62	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	8.02	1.34	2.67	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	9.46	7.10	4.73	0.00	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	30.82	15.41	5.14	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	19.28	13.77	3.44	0.69	1.38	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	11.38	9.40	3.96	0.99	0.00	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	15.70	1.12	5.61	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	12.72	5.09	1.91	0.64	0.00	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	4.43	6.04	3.63	1.21	0.81	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	0.00	6.54	4.36	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	2.53	1.27	2.53	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	6.68	8.50	1.82	0.61	1.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	0.00	9.04	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	9.88	4.94	1.65	0.00	0.00	0.82	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	9.92	7.54	5.16	1.98	0.40	0.00	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	8.44	8.76	4.54	0.32	0.97	0.00	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	18.34	3.06	6.11	1.02	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	17.02	17.02	6.96	3.87	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	5.91	8.27	6.61	1.89	0.94	0.47	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	6.02	9.96	6.95	3.48	0.00	0.23	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	34.19	21.37	4.27	0.00	0.00	8.55	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	24.76	19.32	6.88	2.16	0.72	0.62	0.51
mesothelioma cell line:Mero-25	10850-111F4	28.14	22.47	9.31	2.04	0.91	1.13	0.00
mesothelioma cell line:Mero-41	10851-111F5	22.25	17.36	7.33	3.42	0.49	0.24	0.24
mesothelioma cell line:Mero-48a	10852-111F6	20.37	19.49	8.41	1.77	1.33	0.89	0.22
mesothelioma cell line:Mero-82	10853-111F7	28.91	11.30	4.20	4.73	1.05	0.26	0.26
mesothelioma cell line:Mero-83	10854-111F8	34.55	21.62	9.87	2.38	2.21	0.68	0.00
mesothelioma cell line:Mero-84	10855-111F9	21.23	20.98	8.85	2.02	0.51	0.51	0.00
mesothelioma cell line:Mero-95	10856-111G1	14.49	12.84	6.00	2.48	1.04	0.62	0.41
mesothelioma cell line:NCI-H2052	10847-111F1	36.61	27.50	10.93	4.14	2.15	1.16	0.33
mesothelioma cell line:NCI-H226	10846-111E9	23.17	19.37	5.79	2.35	1.45	0.36	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	12.13	10.42	4.27	1.71	0.34	0.68	0.00
mesothelioma cell line:NCI-H28	10845-111E8	31.81	25.70	14.00	3.56	2.54	0.25	0.76
mesothelioma cell line:No36	10857-111G2	17.61	20.88	5.55	4.57	0.65	0.65	0.00
mesothelioma cell line:ONE58	10858-111G3	30.89	18.42	6.77	2.17	0.54	0.54	0.00
migratory langerhans cells, donor1	11901-125F2	11.13	18.42	14.39	3.26	0.96	0.38	0.38
migratory langerhans cells, donor2	11902-125F3	9.53	16.24	13.19	3.30	0.37	0.73	0.24
migratory langerhans cells, donor3	11903-125F4	13.28	19.38	13.46	5.56	1.62	0.36	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	18.28	12.73	4.90	5.88	0.00	0.98	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	8.05	10.60	4.03	3.39	0.85	0.42	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	14.74	12.44	6.45	4.15	0.46	0.92	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	23.41	15.79	9.13	1.52	0.95	0.57	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	34.37	22.73	8.87	6.47	2.96	1.66	0.37
myeloma cell line:PCM6	10474-106I6	10.48	10.28	3.56	2.37	0.99	0.20	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	25.87	19.28	10.15	2.03	1.01	0.51	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	28.44	21.38	6.86	4.32	2.75	0.98	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	7.91	6.02	1.78	2.12	0.11	1.67	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	9.34	6.99	2.13	1.76	0.29	0.81	0.15
nasal epithelial cells, donor2	12227-129F4	8.83	8.83	2.21	1.66	0.55	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	75.92	49.69	19.56	4.83	4.60	2.07	0.23
neuroblastoma cell line:NB-1	10539-107G8	53.51	46.02	14.59	6.17	4.86	2.25	0.94
neuroblastoma cell line:NBsusSR	10607-108F4	28.47	15.18	7.38	5.27	1.69	0.42	0.42
neuroblastoma cell line:NH-12	10555-107I6	99.70	44.17	10.06	5.40	8.76	0.56	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	8.07	17.79	15.89	2.37	0.95	2.14	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	13.62	19.96	11.56	2.53	0.48	2.85	1.43
neuroectodermal tumor cell line:TASK1	10774-110F9	10.87	13.69	4.63	5.03	1.41	1.01	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	1.91	6.99	31.15	5.09	0.00	3.18	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	8.52	13.84	6.92	5.32	0.53	0.00	0.00
neutrophil PMN, donor1	12133-128D9	29.75	44.62	0.00	0.00	0.00	29.75	0.00
neutrophil PMN, donor2	12137-128E4	53.12	13.28	0.00	13.28	0.00	13.28	0.00
neutrophil PMN, donor3	12141-128E8	18.94	0.00	0.00	0.00	0.00	0.00	9.47
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	94.54	63.25	26.38	13.02	2.71	2.03	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	18.41	16.81	4.00	13.61	3.20	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	7.69	8.34	8.02	2.24	0.32	0.64	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	19.44	11.04	5.78	3.15	0.26	0.53	0.53
nucleus accumbens, adult, pool1	10037-101F1	19.03	20.34	19.87	3.94	0.56	0.75	0.56
occipital cortex - adult, donor10196	10172-103C1	22.66	30.91	22.66	2.06	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	25.49	19.59	11.54	5.37	0.81	0.54	0.27
occipital cortex, newborn, donor10223	10355-105E4	29.12	21.84	10.92	1.82	1.46	1.46	0.00
occipital lobe, adult, donor1	10076-102A4	12.07	14.96	16.27	3.15	1.05	0.00	0.00
occipital lobe, fetal, donor1	10073-102A1	26.18	32.18	40.76	14.59	1.72	0.43	0.43
occipital pole, adult, pool1	10036-101E9	17.66	13.64	12.06	2.76	0.87	0.16	0.08
olfactory region, adult	10195-103E6	12.99	16.62	12.23	4.20	1.15	0.19	0.76
optic nerve, donor1	10277-104E7	18.01	16.01	20.01	10.01	0.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	44.20	15.49	7.97	6.26	1.59	1.14	0.57
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	28.16	19.65	4.81	5.91	0.69	1.51	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	14.22	12.02	6.77	2.54	0.85	1.35	0.68
oral squamous cell carcinoma cell line:SAS	10544-107H4	47.24	15.02	3.81	3.00	2.54	0.46	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	5.88	12.64	6.17	2.06	0.59	0.59	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	21.49	18.69	2.80	4.67	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	14.84	12.94	4.88	4.45	1.27	1.91	0.42
ovary, adult, pool1	10020-101D2	9.08	8.82	8.30	5.15	0.70	0.44	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	14.30	16.32	7.88	3.30	0.92	0.00	0.18
pancreas, adult, donor1	10049-101G4	7.53	8.47	5.64	2.82	2.82	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	20.69	15.93	5.03	3.63	1.68	1.40	0.84
papillary adenocarcinoma cell line:8505C	10437-106E5	40.54	23.34	8.18	3.75	1.36	1.19	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	39.41	17.72	5.80	5.46	2.15	1.32	0.66
paracentral gyrus, adult, pool1	10035-101E8	21.42	17.02	15.10	3.02	0.82	0.27	0.09
parietal cortex, adult, donor10258	10373-105G4	16.15	10.28	22.02	2.20	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	17.87	20.69	16.93	1.88	0.94	0.94	0.94
parietal lobe, adult, donor10252	10157-103A4	20.24	17.67	13.68	4.28	0.86	0.57	0.29
parietal lobe, adult, pool1	10034-101E7	21.06	17.10	14.45	2.03	0.97	0.26	0.09
parietal lobe, fetal, donor1	10072-101I9	37.82	33.94	51.40	4.85	4.85	1.94	0.00
parietal lobe, newborn, donor10223	10356-105E5	32.53	26.54	10.47	1.50	1.50	0.75	0.00
parotid gland, adult	10199-103F1	12.33	3.08	2.47	5.55	1.85	0.62	0.00
penis, adult	10200-103F2	9.67	4.30	7.52	6.45	0.54	0.54	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	6.14	11.71	10.60	1.12	0.37	1.67	0.56
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	21.13	10.93	7.58	3.64	1.75	0.29	0.15
pineal gland - adult, donor10196	10179-103C8	28.38	16.77	13.55	9.03	0.00	0.00	0.65
pineal gland, adult, donor10252	10160-103A7	33.16	33.16	15.40	8.29	0.00	1.78	0.59
pineal gland, adult, donor10258	10377-105G8	30.10	24.46	22.57	4.39	1.25	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	24.28	16.19	4.05	8.09	0.00	2.02	1.01
pituitary gland, adult, donor10252	10162-103A9	41.17	30.75	16.68	15.11	1.04	4.69	1.04
pituitary gland, adult, donor10258	10378-105G9	30.64	23.83	20.43	5.11	1.70	1.70	0.85
placenta, adult, pool1	10021-101D3	9.78	10.43	5.48	3.98	0.65	0.97	0.65
plasma cell leukemia cell line:ARH-77	10840-111E3	32.71	34.96	20.13	4.37	1.19	0.79	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	13.54	11.98	7.63	5.60	0.31	0.31	0.16
pons, adult, pool1	10033-101E6	14.20	15.32	14.46	3.27	1.20	0.34	0.26
postcentral gyrus, adult, pool1	10032-101E5	18.22	14.47	12.81	2.35	1.13	0.26	0.26
promyelocytes/myelocytes PMC, donor1	12132-128D8	37.65	52.28	20.91	14.64	2.09	18.82	6.27
promyelocytes/myelocytes PMC, donor2	12136-128E3	16.52	11.02	5.51	5.51	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	35.21	11.74	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	17.48	22.87	13.11	6.12	1.46	0.73	0.29
prostate cancer cell line:PC-3	10439-106E7	20.87	16.15	6.17	5.45	1.09	0.18	0.18
prostate, adult, pool1	10022-101D4	7.53	7.71	7.98	3.36	1.27	0.45	0.09
putamen, adult, donor10196	10176-103C5	8.50	17.70	21.48	4.01	0.24	0.47	2.36
putamen, adult, donor10252	10152-102I8	11.76	17.65	21.57	0.00	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	24.04	31.69	15.30	5.46	2.19	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	10.39	11.36	25.85	3.38	0.24	0.72	1.45
putamen, newborn, donor10223	10365-105F5	18.74	9.75	12.74	2.25	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	27.35	8.44	2.62	4.95	2.91	1.16	0.00
rectum, fetal, donor1	10067-101I4	25.04	33.38	30.60	4.17	0.00	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	8.27	12.30	4.24	1.48	0.00	0.00	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	7.46	14.08	6.21	0.41	0.00	0.00	0.00
retina, adult, pool1	10030-101E3	13.62	14.21	12.62	4.87	0.70	0.70	0.10
retinoblastoma cell line:Y79	10475-106I7	68.85	44.69	8.31	6.75	7.79	1.82	1.30
rhabdomyosarcoma cell line:KYM-1	10787-110H4	22.38	27.42	12.91	3.69	0.49	0.74	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	80.99	54.27	8.44	13.22	5.62	0.28	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	11.37	5.30	6.82	0.76	0.00	0.76	0.00
salivary acinar cells, donor1	11771-123I7	12.46	11.01	5.18	1.29	3.56	0.00	0.00
salivary acinar cells, donor2	11772-123I8	13.36	11.84	7.44	1.38	2.07	0.14	0.28
salivary acinar cells, donor3	11773-123I9	5.96	6.62	5.30	1.32	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	18.30	8.58	6.29	8.01	0.57	1.14	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	23.02	17.28	8.52	1.43	3.12	0.67	0.51
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	19.16	16.46	6.23	1.53	1.76	0.94	0.71
seminal vesicle, adult	10201-103F3	7.41	10.05	12.70	4.23	1.06	0.53	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	61.22	27.69	13.60	5.59	1.94	1.46	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	10.57	7.05	3.27	0.25	1.51	0.25	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	36.13	32.11	12.04	4.01	0.00	2.01	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	15.72	10.61	6.45	2.28	0.67	1.34	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	62.67	24.10	7.52	3.65	2.98	0.88	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	38.19	16.13	4.52	1.68	3.10	0.39	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	14.19	10.64	0.71	7.80	0.71	1.42	0.00
skeletal muscle, adult, pool1	10023-101D5	14.27	3.36	2.88	4.08	5.76	0.48	0.00
skeletal muscle, fetal, donor1	10066-101I3	24.12	14.07	21.11	6.03	3.02	1.01	0.00
skin, adult, donor1	10074-102A2	6.79	13.57	0.00	0.00	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	11.36	18.94	20.83	6.94	3.16	1.89	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	86.38	63.04	25.68	14.34	1.00	2.67	2.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	64.62	23.96	6.62	11.03	2.21	0.63	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	6.17	17.35	14.07	6.36	0.19	0.58	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	62.63	27.53	6.26	12.20	2.47	1.32	0.49
small cell lung carcinoma cell line:NCI-H82	10842-111E5	11.42	15.76	3.70	4.50	3.22	1.45	0.64
small cell lung carcinoma cell line:WA-hT	10562-108A4	61.45	22.66	5.45	4.58	0.65	0.44	0.44
small intestine, adult, pool1	10024-101D6	23.17	9.91	7.29	4.54	1.31	0.60	0.36
small intestine, fetal, donor1	10064-101I1	14.25	12.53	7.62	3.93	1.97	0.25	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	51.80	27.18	5.13	5.13	2.05	1.03	1.03
smooth muscle, adult, pool1	10048-101G3	4.91	8.27	8.53	5.17	0.78	0.26	0.00
somatostatinoma cell line:QGP-1	10781-110G7	16.89	12.60	4.29	10.18	2.14	1.34	1.07
spinal cord - adult, donor10196	10181-103D1	8.95	15.37	15.14	2.75	1.15	0.46	0.00
spinal cord, adult, donor10252	10159-103A6	14.59	14.98	11.43	2.76	0.39	0.00	0.79
spinal cord, adult, donor10258	10369-105F9	28.36	8.30	15.22	5.53	0.69	1.38	0.00
spinal cord, fetal, donor1	10056-101H2	16.47	14.03	16.47	3.05	1.22	0.61	0.61
spinal cord, newborn, donor10223	10359-105E8	33.98	20.21	16.07	3.21	1.38	0.00	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	10.90	12.99	9.86	2.69	0.30	0.75	0.60
spleen, adult, pool1	10025-101D7	13.33	11.56	11.12	3.41	0.33	0.22	0.33
spleen, fetal, pool1	10044-101F8	14.86	14.06	10.65	3.42	0.56	0.72	0.64
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	15.84	17.60	6.42	4.45	1.76	0.62	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	8.54	7.60	2.85	4.75	0.19	0.57	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	10.48	10.13	6.64	1.75	0.70	0.35	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	41.83	23.85	11.34	6.25	4.30	1.17	1.56
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	37.59	15.87	5.07	3.94	3.04	2.48	0.68
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	18.21	18.64	8.05	8.05	0.00	1.27	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	27.92	19.04	9.31	2.12	0.00	0.00	0.42
stomach, fetal, donor1	10062-101H8	12.82	21.36	21.36	3.20	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	11.39	7.98	12.53	9.11	2.28	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	54.27	0.00	54.27	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	9.14	8.72	8.31	2.70	0.42	0.42	0.00
substantia nigra, adult, donor10258	10371-105G2	24.83	20.17	12.93	1.55	2.07	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	23.32	19.78	10.60	2.12	2.12	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	38.06	47.46	27.51	5.96	1.15	2.06	0.69
temporal lobe, adult, pool1	10031-101E4	13.99	15.26	11.61	1.86	0.68	0.25	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	24.93	26.35	29.92	10.68	1.42	2.14	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	29.01	21.10	15.82	5.71	1.32	0.00	0.00
tenocyte, donor1	11763-123H8	8.73	11.87	8.38	1.40	1.05	0.35	0.00
tenocyte, donor2	11765-123I1	6.87	5.34	3.05	1.53	0.76	0.38	0.00
tenocyte, donor3	11768-123I4	8.90	10.01	6.67	1.48	0.00	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	32.63	20.91	9.35	8.84	1.53	1.87	1.36
teratocarcinoma cell line:NCR-G1	10798-110I6	18.34	16.49	7.09	12.95	0.00	1.70	0.46
teratocarcinoma cell line:PA-1	10807-111A6	15.81	15.81	8.83	15.19	1.70	1.08	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	13.20	12.69	7.24	5.08	0.51	2.03	2.16
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	16.26	11.72	8.70	8.32	1.89	1.13	1.89
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	30.21	18.00	5.89	3.27	4.91	2.40	1.09
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	28.01	23.78	10.10	4.89	3.91	2.61	2.28
testis, adult, pool1	10026-101D8	31.67	20.94	7.52	4.08	1.29	2.68	1.93
testis, adult, pool2	10096-102C6	44.66	25.71	7.22	4.51	0.90	3.61	2.26
thalamus - adult, donor10196	10168-103B6	16.56	13.25	20.98	7.73	1.10	0.00	1.10
thalamus, adult, donor10252	10154-103A1	16.72	16.25	10.16	3.28	0.78	0.47	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	53.89	27.71	21.55	6.16	0.00	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	7.74	9.22	7.41	1.98	0.82	0.00	0.16
thalamus, newborn, donor10223	10366-105F6	16.68	15.53	6.90	0.58	0.58	0.00	0.58
throat, adult	10209-103G2	19.47	9.24	7.24	3.00	0.25	1.25	0.25
throat, fetal, donor1	10061-101H7	12.80	14.63	13.10	8.23	0.91	0.61	1.52
thymic carcinoma cell line:Ty-82	10803-111A2	55.45	44.32	16.89	3.97	3.18	0.60	0.60
thymus, adult, pool1	10027-101D9	7.16	16.50	32.61	3.68	0.40	7.75	6.46
thymus, fetal, pool1	10043-101F7	14.44	18.91	29.40	4.05	0.62	6.13	1.56
thyroid carcinoma cell line:KHM-5M	10776-110G2	27.26	24.46	9.31	3.32	1.60	0.13	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	29.06	24.17	10.48	8.10	1.68	0.84	0.42
thyroid, adult, pool1	10028-101E1	14.00	13.06	7.56	4.48	1.59	1.03	0.09
thyroid, fetal, donor1	10060-101H6	10.02	14.24	15.82	5.27	0.26	1.05	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	24.64	6.16	9.24	0.00	3.08	0.00	0.00
tongue, adult	10203-103F5	10.47	7.21	5.12	2.56	1.16	0.47	0.00
tongue, fetal, donor1	10059-101H5	11.03	7.49	9.06	7.49	4.73	0.39	1.18
tonsil, adult, pool1	10047-101G2	13.12	18.73	20.14	2.70	1.00	1.30	0.10
trachea, adult, pool1	10029-101E2	10.55	9.24	6.30	3.03	0.74	0.82	0.16
trachea, fetal, donor1	10058-101H4	11.54	11.54	13.85	8.46	1.54	1.92	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	16.65	15.23	6.02	2.48	1.06	0.00	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	53.60	36.58	10.33	9.42	3.65	1.11	0.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	25.70	20.37	8.15	6.74	2.04	0.94	0.00
tridermal teratoma cell line:HGRT	10694-109G1	11.42	9.51	5.71	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	33.52	16.08	7.96	1.44	1.61	0.42	0.42
umbilical cord, fetal, donor1	10057-101H3	8.35	6.26	10.43	6.26	0.00	0.00	2.09
uterus, adult, pool1	10100-102D1	13.65	13.48	10.92	7.85	0.85	1.19	0.51
uterus, fetal, donor1	10055-101H1	9.73	19.97	23.55	3.58	1.54	0.51	0.00
vagina, adult	10204-103F6	10.34	7.75	6.46	3.23	0.00	1.29	0.00
vein, adult	10191-103E2	7.67	12.93	16.44	2.85	0.88	0.22	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	8.28	11.22	6.68	1.07	1.34	0.27	0.00